| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 2.29e-07 | 46 | 281 | 8 | GO:0005245 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 9.61e-07 | 14 | 281 | 5 | GO:0008331 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | CACNA2D2 ABCC8 PKD2 KCNMA1 CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F LRRC38 KCNK13 OPRM1 | 1.69e-06 | 152 | 281 | 12 | GO:0022843 |
| GeneOntologyMolecularFunction | neuropeptide receptor activity | 8.99e-06 | 53 | 281 | 7 | GO:0008188 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | CACNA2D2 ABCC8 PKD2 KCNMA1 CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F LRRC38 KCNK13 OPRM1 | 1.09e-05 | 182 | 281 | 12 | GO:0005244 |
| GeneOntologyMolecularFunction | neuropeptide binding | 1.19e-05 | 37 | 281 | 6 | GO:0042923 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | CACNA2D2 ABCC8 PKD2 KCNMA1 CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F LRRC38 KCNK13 OPRM1 | 1.21e-05 | 184 | 281 | 12 | GO:0022832 |
| GeneOntologyMolecularFunction | gated channel activity | CACNA2D2 ABCC8 PKD2 KCNMA1 CNGA3 CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F LRRC38 KCNK13 OPRM1 P2RX7 TMC5 GABRA6 | 2.25e-05 | 334 | 281 | 16 | GO:0022836 |
| GeneOntologyMolecularFunction | lysophosphatidic acid receptor activity | 2.70e-05 | 5 | 281 | 3 | GO:0070915 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | CACNA2D2 SLC8B1 PKD2 CNGA3 CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F OPRM1 | 5.69e-05 | 151 | 281 | 10 | GO:0015085 |
| GeneOntologyMolecularFunction | calcium channel activity | CACNA2D2 PKD2 CNGA3 CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F OPRM1 | 8.95e-05 | 129 | 281 | 9 | GO:0005262 |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 1.13e-04 | 133 | 281 | 9 | GO:0008528 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 1.67e-04 | 140 | 281 | 9 | GO:0001653 | |
| GeneOntologyMolecularFunction | corticosterone 18-monooxygenase activity | 1.97e-04 | 2 | 281 | 2 | GO:0047783 | |
| GeneOntologyMolecularFunction | steroid 11-beta-monooxygenase activity | 1.97e-04 | 2 | 281 | 2 | GO:0004507 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 2.18e-04 | 9 | 281 | 3 | GO:0099626 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 2.18e-04 | 9 | 281 | 3 | GO:0099511 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.68e-04 | 118 | 281 | 8 | GO:0003774 | |
| GeneOntologyMolecularFunction | single-stranded DNA exodeoxyribonuclease activity | 3.08e-04 | 10 | 281 | 3 | GO:0008297 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA2D2 SLC8B1 ABCC8 PKD2 KCNMA1 CNGA3 CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F LRRC38 KCNK13 OPRM1 TFRC SLC28A2 SLC4A4 | 3.40e-04 | 465 | 281 | 17 | GO:0046873 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | GALR1 ADGRB2 ADGRV1 ADGRE2 SSTR4 PROKR1 ADRA1D PTPRB PROKR2 ABCC8 SEMA6A TAS2R40 TAS2R30 OR5L2 MRC1 HTR1A NPY6R LPAR4 GPER1 GPR34 CCRL2 SEMA5A OPRL1 OPRM1 OR9A1P MST1R P2RX7 LPAR6 TLR4 TLR5 MRGPRX4 RXFP4 LPAR2 OR52B6 GABRA6 | 3.64e-04 | 1353 | 281 | 35 | GO:0004888 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | CACNA2D2 ABCC8 PKD2 KCNMA1 CNGA3 CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F LRRC38 KCNK13 OPRM1 P2RX7 | 3.83e-04 | 343 | 281 | 14 | GO:0005261 |
| GeneOntologyMolecularFunction | neuropeptide Y receptor activity | 4.18e-04 | 11 | 281 | 3 | GO:0004983 | |
| GeneOntologyMolecularFunction | phosphatidylinositol kinase activity | 4.50e-04 | 26 | 281 | 4 | GO:0052742 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 4.54e-04 | 70 | 281 | 6 | GO:0003777 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ABCC4 CACNA2D2 NDUFS3 SLC8B1 ABCC8 PKD2 KCNMA1 CNGA3 CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F LRRC38 KCNK13 AQP2 AQP5 OPRM1 TFRC SLC17A5 SLC28A2 SLC4A4 GABRA6 | 4.79e-04 | 758 | 281 | 23 | GO:0015318 |
| GeneOntologyMolecularFunction | channel activity | CACNA2D2 ABCC8 PKD2 KCNMA1 CNGA3 CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F LRRC38 KCNK13 AQP2 AQP5 OPRM1 P2RX7 TMC5 GABRA6 | 4.92e-04 | 525 | 281 | 18 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | CACNA2D2 ABCC8 PKD2 KCNMA1 CNGA3 CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F LRRC38 KCNK13 AQP2 AQP5 OPRM1 P2RX7 TMC5 GABRA6 | 5.03e-04 | 526 | 281 | 18 | GO:0022803 |
| GeneOntologyMolecularFunction | nuclear export signal receptor activity | 5.52e-04 | 12 | 281 | 3 | GO:0005049 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 6.02e-04 | 28 | 281 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | GALR1 ADGRB2 ADGRV1 ADGRE2 SSTR4 PROKR1 ADRA1D PROKR2 TAS2R40 TAS2R30 OR5L2 HTR1A NPY6R LPAR4 GPER1 GPR34 CCRL2 OPRL1 OPRM1 OR9A1P LPAR6 MRGPRX4 RXFP4 LPAR2 OR52B6 | 7.61e-04 | 884 | 281 | 25 | GO:0004930 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CACNA2D2 ABCC8 PKD2 KCNMA1 CNGA3 CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F LRRC38 KCNK13 OPRM1 P2RX7 TMC5 GABRA6 | 8.42e-04 | 459 | 281 | 16 | GO:0005216 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | GBF1 STARD8 TSC2 ARHGAP11A IQGAP1 DLC1 ARHGAP29 FGD1 RIC1 PREX2 DENND3 ARFGEF3 NPRL2 DENND6A FARP1 TNK2 NCKAP1L | 8.97e-04 | 507 | 281 | 17 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | GBF1 STARD8 TSC2 ARHGAP11A IQGAP1 DLC1 ARHGAP29 FGD1 RIC1 PREX2 DENND3 ARFGEF3 NPRL2 DENND6A FARP1 TNK2 NCKAP1L | 8.97e-04 | 507 | 281 | 17 | GO:0030695 |
| GeneOntologyMolecularFunction | nucleocytoplasmic carrier activity | 1.01e-03 | 32 | 281 | 4 | GO:0140142 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol 4-kinase activity | 1.16e-03 | 4 | 281 | 2 | GO:0004430 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA2D2 NDUFS3 SLC8B1 ABCC8 PKD2 KCNMA1 CNGA3 CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F LRRC38 KCNK13 OPRM1 TFRC SLC17A5 P2RX7 SLC28A2 SLC4A4 | 1.22e-03 | 664 | 281 | 20 | GO:0008324 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ABCC4 CACNA2D2 ABCA13 NDUFS3 SLC8B1 ABCC8 PKD2 KCNMA1 ABCD1 CNGA3 CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F LRRC38 SLC19A3 MFSD2B KCNK13 AQP2 AQP5 OPRM1 TFRC SLC17A5 CNNM3 P2RX7 SLC28A2 SLC4A4 TMC5 GABRA6 | 1.28e-03 | 1180 | 281 | 30 | GO:0022857 |
| GeneOntologyMolecularFunction | bioactive lipid receptor activity | 1.35e-03 | 16 | 281 | 3 | GO:0045125 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA2D2 NDUFS3 SLC8B1 ABCC8 PKD2 KCNMA1 CNGA3 CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F LRRC38 KCNK13 OPRM1 TFRC SLC17A5 SLC28A2 SLC4A4 | 1.50e-03 | 627 | 281 | 19 | GO:0022890 |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.76e-03 | 37 | 281 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in cardiac muscle cell action potential | 1.92e-03 | 5 | 281 | 2 | GO:0086007 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.92e-03 | 18 | 281 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA2D2 NDUFS3 SLC8B1 ABCC8 PKD2 KCNMA1 CNGA3 CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F LRRC38 KCNK13 OPRM1 TFRC SLC17A5 P2RX7 SLC28A2 SLC4A4 TMC5 GABRA6 | 1.99e-03 | 793 | 281 | 22 | GO:0015075 |
| GeneOntologyMolecularFunction | small GTPase binding | NCKAP1 MYO5A TSC2 IQGAP1 FGD1 RIC1 ANKFY1 XPO4 RANBP17 IPO9 FARP1 XPO7 | 2.08e-03 | 321 | 281 | 12 | GO:0031267 |
| GeneOntologyMolecularFunction | calcium ion binding | EFCAB5 REPS1 MYO5A ADGRV1 ADGRE2 LRP1B TENM2 ITIH4 IQGAP1 PKD2 CACNA1E NAALADL1 PCDHGB6 PCDHGB5 ASAH2 FAT3 CRB1 MCTP1 GUCA1B SLIT1 PCDHGB4 | 2.21e-03 | 749 | 281 | 21 | GO:0005509 |
| GeneOntologyMolecularFunction | transporter activity | ABCC4 CACNA2D2 ABCA13 NDUFS3 SLC8B1 ABCC8 PKD2 KCNMA1 ABCD1 CNGA3 CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F LRRC38 SLC19A3 MFSD2B KCNK13 AQP2 AQP5 ATP8B2 OPRM1 TFRC SLC17A5 CNNM3 P2RX7 SLC28A2 SLC4A4 TMC5 GABRA6 | 2.51e-03 | 1289 | 281 | 31 | GO:0005215 |
| GeneOntologyMolecularFunction | lipid kinase activity | 2.58e-03 | 41 | 281 | 4 | GO:0001727 | |
| GeneOntologyMolecularFunction | single-stranded DNA 3'-5' DNA exonuclease activity | 2.85e-03 | 6 | 281 | 2 | GO:0008310 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol phosphate biosynthetic process | 3.11e-06 | 66 | 281 | 8 | GO:0046854 | |
| GeneOntologyBiologicalProcess | neuropeptide signaling pathway | GALR1 SSTR4 PROKR1 PROKR2 NPY6R CALCA OPRL1 OPRM1 MRGPRX4 RXFP4 | 7.82e-06 | 124 | 281 | 10 | GO:0007218 |
| GeneOntologyCellularComponent | photoreceptor cell cilium | IMPG1 MYO5A ADGRV1 SPTBN5 NXNL1 CNGA3 CACNA1F CRB1 GUCA1B IFT88 | 2.09e-05 | 139 | 284 | 10 | GO:0097733 |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 3.54e-05 | 46 | 284 | 6 | GO:0005891 | |
| GeneOntologyCellularComponent | 9+0 non-motile cilium | IMPG1 MYO5A ADGRV1 SPTBN5 NXNL1 CNGA3 CACNA1F CRB1 GUCA1B IFT88 | 4.76e-05 | 153 | 284 | 10 | GO:0097731 |
| GeneOntologyCellularComponent | non-motile cilium | IMPG1 MYO5A ADGRV1 SPTBN5 NXNL1 PKD2 CNGA3 CACNA1F CRB1 GUCA1B IFT88 | 8.05e-05 | 196 | 284 | 11 | GO:0097730 |
| GeneOntologyCellularComponent | photoreceptor outer segment | 1.39e-04 | 111 | 284 | 8 | GO:0001750 | |
| GeneOntologyCellularComponent | cilium | TMEM67 ABCC4 IMPG1 MYO5A JADE1 ADGRV1 BBS9 PIK3R4 SPTBN5 NXNL1 AKAP4 PKD2 TAS2R30 DNAH6 DNAH8 CNGA3 CACNA1F PRAMEF22 LZTFL1 TMEM138 CFAP43 CRB1 DNAH12 GUCA1B IFT88 CFAP44 | 2.48e-04 | 898 | 284 | 26 | GO:0005929 |
| GeneOntologyCellularComponent | vesicle membrane | TSPAN15 PI4K2B TMEM67 ABCC4 MANBA ABCA13 PLD3 ITGAM TLR8 IQGAP1 PIK3R4 UBA1 PTPRB PI4KA ABCC8 SNX8 PKD2 CKAP4 DSE GLIPR1 MRC1 ANKFY1 GPER1 AQP2 AQP5 TFRC ARFGEF3 SLC17A5 MCTP1 IFT88 TLR4 SLC28A2 TNK2 NCKAP1L | 2.74e-04 | 1325 | 284 | 34 | GO:0012506 |
| GeneOntologyCellularComponent | trans-Golgi network | PI4K2B GBF1 PIK3C2A RIC1 COG2 RELCH GPER1 SMPD4 AQP2 ATP8B2 AP4E1 IFT88 LRBA | 3.04e-04 | 306 | 284 | 13 | GO:0005802 |
| GeneOntologyCellularComponent | cation channel complex | CACNA2D2 ABCC8 PKD2 KCNMA1 CNGA3 CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F LRRC38 | 3.91e-04 | 235 | 284 | 11 | GO:0034703 |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | TSPAN15 PI4K2B TMEM67 ABCC4 MANBA ABCA13 PLD3 ITGAM TLR8 IQGAP1 PIK3R4 UBA1 PTPRB PI4KA ABCC8 SNX8 PKD2 CKAP4 DSE GLIPR1 MRC1 ANKFY1 GPER1 AQP2 AQP5 TFRC ARFGEF3 SLC17A5 MCTP1 IFT88 TLR4 TNK2 NCKAP1L | 4.51e-04 | 1307 | 284 | 33 | GO:0030659 |
| GeneOntologyCellularComponent | calcium channel complex | 4.74e-04 | 73 | 284 | 6 | GO:0034704 | |
| GeneOntologyCellularComponent | vacuolar membrane | MANBA ABCA13 TSC2 PLD3 TLR8 UBA1 ATXN3 FNIP1 ABCD1 CKAP4 GLIPR1 ANKFY1 TMEM138 TSPAN1 SLC17A5 NPRL2 LRBA | 6.12e-04 | 507 | 284 | 17 | GO:0005774 |
| GeneOntologyCellularComponent | lysosomal membrane | MANBA ABCA13 TSC2 PLD3 TLR8 UBA1 ATXN3 FNIP1 ABCD1 CKAP4 GLIPR1 ANKFY1 TSPAN1 SLC17A5 NPRL2 LRBA | 6.25e-04 | 462 | 284 | 16 | GO:0005765 |
| GeneOntologyCellularComponent | lytic vacuole membrane | MANBA ABCA13 TSC2 PLD3 TLR8 UBA1 ATXN3 FNIP1 ABCD1 CKAP4 GLIPR1 ANKFY1 TSPAN1 SLC17A5 NPRL2 LRBA | 6.25e-04 | 462 | 284 | 16 | GO:0098852 |
| GeneOntologyCellularComponent | phosphatidylinositol 3-kinase complex, class III, type II | 1.08e-03 | 4 | 284 | 2 | GO:0034272 | |
| GeneOntologyCellularComponent | phosphatidylinositol 3-kinase complex, class III, type I | 1.08e-03 | 4 | 284 | 2 | GO:0034271 | |
| GeneOntologyCellularComponent | cell leading edge | GBF1 NCKAP1 MYO5A ADGRV1 ADGRE2 IQGAP1 SH3YL1 DLC1 PKD2 FGD1 CACNA1D GPER1 CARMIL1 OPRM1 TLR4 GABRA6 | 1.43e-03 | 500 | 284 | 16 | GO:0031252 |
| GeneOntologyCellularComponent | presynaptic membrane | CACNA2D2 KCNMA1 CACNA1A CACNA1C CACNA1D CACNA1E HTR1A GPER1 OPRM1 LPAR2 GABRA6 | 1.50e-03 | 277 | 284 | 11 | GO:0042734 |
| HumanPheno | Polydipsia | 1.18e-05 | 53 | 107 | 8 | HP:0001959 | |
| Domain | ARM-type_fold | STK36 GBF1 TSC2 TRIP12 LYST PIK3R4 URB1 PSME4 PIK3C2A PI4KA UNC79 RELCH ARMC7 USP24 XPO4 ARFGEF3 RANBP17 AP4E1 IPO9 ELMO2 EFR3B LRBA XPO7 | 1.85e-09 | 339 | 280 | 23 | IPR016024 |
| Domain | Ca_chan_IQ | 1.50e-08 | 7 | 280 | 5 | SM01062 | |
| Domain | GPHH_dom | 1.50e-08 | 7 | 280 | 5 | IPR031649 | |
| Domain | Ca_chan_IQ | 1.50e-08 | 7 | 280 | 5 | PF08763 | |
| Domain | VDCC_a1su_IQ | 1.50e-08 | 7 | 280 | 5 | IPR014873 | |
| Domain | GPHH | 1.50e-08 | 7 | 280 | 5 | PF16905 | |
| Domain | VDCCAlpha1 | 1.73e-07 | 10 | 280 | 5 | IPR002077 | |
| Domain | CAC1F_C | 3.33e-06 | 3 | 280 | 3 | IPR031688 | |
| Domain | CAC1F_C | 3.33e-06 | 3 | 280 | 3 | PF16885 | |
| Domain | - | STK36 TSC2 TRIP12 PIK3R4 PSME4 RELCH ARMC7 XPO4 RANBP17 AP4E1 IPO9 ELMO2 EFR3B LRBA | 6.92e-06 | 222 | 280 | 14 | 1.25.10.10 |
| Domain | - | EDC4 LYST DMXL1 PIK3R4 WDR3 NUP37 SEMA6A RIC1 SEMA5A CFAP43 DENND3 MST1R PPP2R2C GTF3C2 LRBA MAPKBP1 CFAP44 | 1.22e-05 | 333 | 280 | 17 | 2.130.10.10 |
| Domain | VDCC_L_a1su | 1.32e-05 | 4 | 280 | 3 | IPR005446 | |
| Domain | WD40/YVTN_repeat-like_dom | EDC4 LYST DMXL1 PIK3R4 WDR3 NUP37 SEMA6A RIC1 SEMA5A CFAP43 DENND3 MST1R PPP2R2C GTF3C2 LRBA MAPKBP1 CFAP44 | 1.32e-05 | 335 | 280 | 17 | IPR015943 |
| Domain | ARM-like | STK36 TSC2 TRIP12 PIK3R4 PSME4 RELCH ARMC7 XPO4 RANBP17 AP4E1 IPO9 ELMO2 EFR3B LRBA XPO7 | 1.49e-05 | 270 | 280 | 15 | IPR011989 |
| Domain | Cys-rich_flank_reg_C | 6.18e-05 | 90 | 280 | 8 | IPR000483 | |
| Domain | LRRCT | 6.18e-05 | 90 | 280 | 8 | SM00082 | |
| Domain | WD_REPEATS_1 | EDC4 LYST DMXL1 PIK3R4 WDR3 NUP37 RIC1 CFAP43 DENND3 PPP2R2C GTF3C2 LRBA MAPKBP1 CFAP44 | 8.34e-05 | 278 | 280 | 14 | PS00678 |
| Domain | WD_REPEATS_2 | EDC4 LYST DMXL1 PIK3R4 WDR3 NUP37 RIC1 CFAP43 DENND3 PPP2R2C GTF3C2 LRBA MAPKBP1 CFAP44 | 8.66e-05 | 279 | 280 | 14 | PS50082 |
| Domain | WD_REPEATS_REGION | EDC4 LYST DMXL1 PIK3R4 WDR3 NUP37 RIC1 CFAP43 DENND3 PPP2R2C GTF3C2 LRBA MAPKBP1 CFAP44 | 8.66e-05 | 279 | 280 | 14 | PS50294 |
| Domain | LRRCT | 1.06e-04 | 32 | 280 | 5 | PF01463 | |
| Domain | WD40_repeat_dom | EDC4 LYST DMXL1 PIK3R4 WDR3 NUP37 RIC1 CFAP43 DENND3 PPP2R2C GTF3C2 LRBA MAPKBP1 CFAP44 | 1.67e-04 | 297 | 280 | 14 | IPR017986 |
| Domain | - | 2.06e-04 | 57 | 280 | 6 | 1.20.120.350 | |
| Domain | Channel_four-helix_dom | 2.06e-04 | 57 | 280 | 6 | IPR027359 | |
| Domain | WD40 | EDC4 LYST DMXL1 PIK3R4 WDR3 NUP37 CFAP43 DENND3 PPP2R2C GTF3C2 LRBA MAPKBP1 CFAP44 | 2.15e-04 | 268 | 280 | 13 | SM00320 |
| Domain | Nck-associated_protein-1 | 2.24e-04 | 2 | 280 | 2 | IPR019137 | |
| Domain | Cyt_P450_mitochondrial | 2.24e-04 | 2 | 280 | 2 | IPR002399 | |
| Domain | Nckap1 | 2.24e-04 | 2 | 280 | 2 | PF09735 | |
| Domain | WD40_repeat | EDC4 LYST DMXL1 PIK3R4 WDR3 NUP37 CFAP43 DENND3 PPP2R2C GTF3C2 LRBA MAPKBP1 CFAP44 | 2.49e-04 | 272 | 280 | 13 | IPR001680 |
| Domain | LRR_1 | LRRC24 LRRC45 TLR8 LRRC38 SLIT1 TLR4 TLR5 RTN4RL2 PRAME LRRD1 TPBG | 4.88e-04 | 219 | 280 | 11 | PF00560 |
| Domain | Leu-rich_rpt | LRRC24 LRRC45 TLR8 LRRC38 CARMIL1 SLIT1 TLR4 TLR5 RTN4RL2 PRAME LRRD1 TPBG | 8.39e-04 | 271 | 280 | 12 | IPR001611 |
| Domain | ATPase_dyneun-rel_AAA | 1.07e-03 | 14 | 280 | 3 | IPR011704 | |
| Domain | AAA_8 | 1.07e-03 | 14 | 280 | 3 | PF12780 | |
| Domain | AAA_5 | 1.07e-03 | 14 | 280 | 3 | PF07728 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.07e-03 | 14 | 280 | 3 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 1.07e-03 | 14 | 280 | 3 | IPR013602 | |
| Domain | DHC_N2 | 1.07e-03 | 14 | 280 | 3 | PF08393 | |
| Domain | LRR_8 | 1.13e-03 | 171 | 280 | 9 | PF13855 | |
| Domain | - | LRRC24 LRRC45 TLR8 LRRC38 PRAMEF22 CARMIL1 SLIT1 TLR4 TLR5 RTN4RL2 PRAME LRRD1 TPBG | 1.17e-03 | 321 | 280 | 13 | 3.80.10.10 |
| Domain | Opioid_rcpt | 1.32e-03 | 4 | 280 | 2 | IPR001418 | |
| Domain | - | 1.32e-03 | 4 | 280 | 2 | 1.10.3240.10 | |
| Domain | UBQ-activ_enz_E1_CS | 1.32e-03 | 4 | 280 | 2 | IPR018074 | |
| Domain | UBQ-activ_enz_E1_Cys_AS | 1.32e-03 | 4 | 280 | 2 | IPR033127 | |
| Domain | IBN_N | 1.33e-03 | 15 | 280 | 3 | PF03810 | |
| Domain | DHC_fam | 1.33e-03 | 15 | 280 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 1.33e-03 | 15 | 280 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 1.33e-03 | 15 | 280 | 3 | IPR004273 | |
| Domain | L_dom-like | LRRC24 LRRC45 TLR8 LRRC38 PRAMEF22 CARMIL1 SLIT1 TLR4 TLR5 RTN4RL2 PRAME LRRD1 TPBG | 1.42e-03 | 328 | 280 | 13 | IPR032675 |
| Domain | Leu-rich_rpt_typical-subtyp | 1.44e-03 | 177 | 280 | 9 | IPR003591 | |
| Domain | LRR_TYP | 1.44e-03 | 177 | 280 | 9 | SM00369 | |
| Domain | 7TM_GPCR_Srsx | 1.50e-03 | 112 | 280 | 7 | SM01381 | |
| Domain | AAA+_ATPase | 1.50e-03 | 144 | 280 | 8 | IPR003593 | |
| Domain | AAA | 1.50e-03 | 144 | 280 | 8 | SM00382 | |
| Domain | IBN_N | 1.62e-03 | 16 | 280 | 3 | SM00913 | |
| Domain | Ion_trans_dom | 1.66e-03 | 114 | 280 | 7 | IPR005821 | |
| Domain | Ion_trans | 1.66e-03 | 114 | 280 | 7 | PF00520 | |
| Pathway | WP_GPCRS_NONODORANT | GALR1 ADGRB2 ADGRE2 SSTR4 PROKR1 ADRA1D PROKR2 TAS2R40 HTR1A NPY6R LPAR4 GPER1 CCRL2 OPRM1 LPAR6 RXFP4 LPAR2 | 5.60e-07 | 266 | 212 | 17 | MM15843 |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 1.50e-06 | 25 | 212 | 6 | M47948 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 1.98e-05 | 23 | 212 | 5 | M47666 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 6.49e-05 | 6 | 212 | 3 | M47762 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | GALR1 ADGRE2 SSTR4 PROKR1 ADRA1D PROKR2 TAS2R40 TAS2R30 HTR1A CALCA LPAR4 GPER1 CCRL2 OPRL1 OPRM1 LPAR6 RXFP4 LPAR2 | 8.90e-05 | 430 | 212 | 18 | MM15160 |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE | 1.29e-04 | 18 | 212 | 4 | M645 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE | 1.29e-04 | 18 | 212 | 4 | MM14642 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 1.69e-04 | 78 | 212 | 7 | M1921 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | GALR1 ADGRE2 SSTR4 PROKR1 ADRA1D PROKR2 TAS2R40 TAS2R30 HTR1A CALCA LPAR4 GPER1 CCRL2 OPRL1 OPRM1 LPAR6 RXFP4 LPAR2 | 2.23e-04 | 463 | 212 | 18 | M507 |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 2.95e-04 | 142 | 212 | 9 | MM15576 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 3.00e-04 | 61 | 212 | 6 | MM15071 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | STARD8 NCKAP1 ARHGAP11A NDUFS3 IQGAP1 DLC1 ARHGAP29 FGD1 KIF14 CKAP4 ANKFY1 LBR PREX2 TFRC ELMO2 FARP1 NCKAP1L | 3.50e-04 | 439 | 212 | 17 | MM15595 |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 4.21e-04 | 149 | 212 | 9 | M41805 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | STARD8 NCKAP1 ARHGAP11A NDUFS3 IQGAP1 DLC1 ARHGAP29 FGD1 KIF14 CKAP4 ANKFY1 LBR PREX2 TFRC ELMO2 FARP1 NCKAP1L | 4.65e-04 | 450 | 212 | 17 | M27078 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | GALR1 SSTR4 PROKR1 ADRA1D PROKR2 HTR1A LPAR4 GPER1 CCRL2 OPRL1 OPRM1 LPAR6 RXFP4 LPAR2 | 4.78e-04 | 330 | 212 | 14 | M18334 |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 5.06e-04 | 11 | 212 | 3 | MM14498 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 5.06e-04 | 11 | 212 | 3 | M26913 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 5.06e-04 | 11 | 212 | 3 | M47958 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | GALR1 SSTR4 ADRA1D HTR1A NPY6R GPER1 GPR34 CCRL2 OPRL1 OPRM1 | 5.14e-04 | 186 | 212 | 10 | MM15994 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | GALR1 SSTR4 PROKR1 ADRA1D PROKR2 HTR1A LPAR4 GPER1 CCRL2 OPRL1 OPRM1 LPAR6 RXFP4 LPAR2 | 5.23e-04 | 333 | 212 | 14 | MM14963 |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 5.33e-04 | 94 | 212 | 7 | MM15598 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 5.61e-04 | 155 | 212 | 9 | M41808 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | GALR1 SSTR4 ADRA1D HTR1A NPY6R LPAR4 GPER1 GPR34 CCRL2 OPRL1 OPRM1 LPAR6 | 5.78e-04 | 260 | 212 | 12 | M39397 |
| Pathway | KEGG_TYPE_II_DIABETES_MELLITUS | 6.73e-04 | 47 | 212 | 5 | M19708 | |
| Pubmed | ABCC4 GBF1 TSC2 LYST DMXL1 PIK3R4 PTPN1 PI4KA FNIP1 CKAP4 RIC1 UBE2J1 COG2 ST7 GPAT3 LBR ARFGEF3 VPS13D CDK5RAP3 NUP155 EXD2 LRBA | 2.78e-10 | 504 | 286 | 22 | 34432599 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ABCC4 MYO5A CACNA2D2 ERV3-1 TSPYL2 TMPRSS5 ADGRV1 PLD3 NDUFS3 SH3YL1 SLC8B1 PTPRB ABCC8 PKD2 KCNMA1 FNIP1 SEMA6A POLK RIC1 CACNA1C POLR1A ST7 CARMIL1 POLG SAMD4B RNF213 OPRL1 ARFGEF3 RANBP17 ZNF708 PPP2R2C FARP1 NAT10 PLEKHA2 TNK2 GREB1 LRBA XPO7 | 6.86e-10 | 1489 | 286 | 38 | 28611215 |
| Pubmed | 1.38e-09 | 15 | 286 | 6 | 20188150 | ||
| Pubmed | 1.38e-09 | 15 | 286 | 6 | 24453333 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | NCKAP1 TSC2 EDC4 PLD3 TRIP12 NDUFS3 IQGAP1 YIF1A URB1 LMF2 SARS1 PI4KA EIF3L ABCD1 CKAP4 ANAPC5 POLR1A TUT7 USP24 LBR TFRC RNF170 ARFGEF3 CNNM3 IPO9 NUP155 EXD2 ESPL1 XPO7 | 1.40e-09 | 942 | 286 | 29 | 31073040 |
| Pubmed | 2.22e-08 | 5 | 286 | 4 | 11296258 | ||
| Pubmed | 2.22e-08 | 5 | 286 | 4 | 15451373 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | STK36 GBF1 REPS1 LRRC24 NAGLU ADGRB2 TSC2 JADE1 EDC4 LYST MAP3K5 URB1 SLC8B1 PSME4 PI4KA SNX8 ABCD1 MED13 RIC1 ENGASE CTC1 POLG CFAP43 FBXO46 MST1R TNK2 LRBA MAPKBP1 ESPL1 | 4.65e-08 | 1105 | 286 | 29 | 35748872 |
| Pubmed | GBF1 NCKAP1 EDC4 IQGAP1 WDR3 UBA1 SARS1 EIF3L CKAP4 CUL4B ANKFY1 BAG5 USP24 LBR THOC2 TFRC IPO9 NUP155 NAT10 LRBA PCBP2 | 9.48e-08 | 638 | 286 | 21 | 33239621 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | TSC2 NDUFS3 SPTBN5 WDR3 PTPN1 LMF2 SARS1 PIK3C2A NUP37 PI4KA ATXN3 CKAP4 GNL1 UBE2J1 FOXRED1 ST7 POLG TUT7 BAG5 GPAT3 RNF213 SMPD4 LBR NCOA5 ARFGEF3 VPS13D CDK5RAP3 NUP155 GTF3C2 MRPS2 EXD2 NAT10 ESPL1 PRAME | 9.69e-08 | 1496 | 286 | 34 | 32877691 |
| Pubmed | PtdIns4P synthesis by PI4KIIIα at the plasma membrane and its impact on plasma membrane identity. | 1.54e-07 | 7 | 286 | 4 | 23229899 | |
| Pubmed | 1.54e-07 | 7 | 286 | 4 | 12900400 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | CACNA2D2 ABCC8 KCNMA1 CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F KCNK13 P2RX7 | 2.53e-07 | 139 | 286 | 10 | 16985003 |
| Pubmed | PI4K2B ABCC4 GBF1 MYO5A EDC4 CCDC88B PIK3R4 LMF2 PIK3C2A PI4KA EIF3L KIF14 ABCD1 MED13 GLIPR1 BAG5 RNF213 LBR CNNM3 CDK5RAP3 IPO9 NUP155 DCP1B NAT10 TNK2 LRBA PCBP2 NCKAP1L | 4.99e-07 | 1168 | 286 | 28 | 19946888 | |
| Pubmed | 5.46e-07 | 9 | 286 | 4 | 16382099 | ||
| Pubmed | 5.50e-07 | 3 | 286 | 3 | 17984374 | ||
| Pubmed | 5.50e-07 | 3 | 286 | 3 | 23338940 | ||
| Pubmed | PI4K2B REPS1 TSC2 EDC4 PLD3 ARHGAP11A IQGAP1 WDR3 PTPN1 URB1 PIK3C2A EIF3L KIF14 CKAP4 COG2 ST7 BAG5 XPO4 RNF213 SMPD4 LBR THOC2 TFRC ARFGEF3 IPO9 NUP155 MRPS2 TNFSF13B NAT10 SERPINE1 PCBP2 | 1.17e-06 | 1440 | 286 | 31 | 30833792 | |
| Pubmed | 2.10e-06 | 12 | 286 | 4 | 11700294 | ||
| Pubmed | 2.19e-06 | 4 | 286 | 3 | 20937870 | ||
| Pubmed | Cerebellar granule cell signaling is indispensable for normal motor performance. | 2.19e-06 | 4 | 286 | 3 | 37141091 | |
| Pubmed | 2.65e-06 | 105 | 286 | 8 | 9628581 | ||
| Pubmed | REPS1 PDE7A MYO5A TSPYL2 USP25 TSC2 FTCD CMYA5 TRIP12 LRP1B IQGAP1 SH3YL1 PIK3R4 WDR3 TTC7B HPF1 MED13 GLIPR1 COG2 FOXRED1 POLG DNAAF9 CRYL1 NPRL2 IFT88 GUCY1B1 PDE4DIP LRBA | 3.16e-06 | 1285 | 286 | 28 | 35914814 | |
| Pubmed | TNFRSF9 STARD8 CHAC2 JADE1 ADGRE2 TRIP12 URB1 PSME4 PI4KA POLK DSE CTC1 PRAMEF22 POLG TUT7 THOC2 TBCCD1 CDK5RAP3 P2RX7 FARP1 NAT10 TLR4 LPAR2 ESPL1 NCKAP1L | 4.13e-06 | 1084 | 286 | 25 | 11544199 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | NCKAP1 TOPAZ1 TRIP12 PIK3R4 PTPRB SARS1 KIF2B SEPTIN1 RIC1 CACNA1C POLR1A CARMIL1 VPS13D DNAH12 KIAA0825 LRBA | 4.37e-06 | 497 | 286 | 16 | 36774506 |
| Pubmed | DMXL1 PTPN1 PTPN9 PIK3C2A UBE2J1 RELCH SMPD4 TFRC AP4E1 DENND6A TNK2 LRBA | 4.93e-06 | 285 | 286 | 12 | 34369648 | |
| Pubmed | Molecular mechanism of lysophosphatidic acid-induced hypertensive response. | 5.44e-06 | 5 | 286 | 3 | 30804442 | |
| Pubmed | The leukodystrophy protein FAM126A (hyccin) regulates PtdIns(4)P synthesis at the plasma membrane. | 5.44e-06 | 5 | 286 | 3 | 26571211 | |
| Pubmed | TLR agonists downregulate H2-O in CD8alpha- dendritic cells. | 5.44e-06 | 5 | 286 | 3 | 21918198 | |
| Pubmed | Lysophospholipid receptor nomenclature review: IUPHAR Review 8. | 5.69e-06 | 15 | 286 | 4 | 24602016 | |
| Pubmed | NCKAP1 LRRC24 MYO5A ADGRB2 TSC2 EDC4 TENM2 ITIH4 MAP3K5 IQGAP1 PTPN9 UBA1 PI4KA KCNMA1 UNC79 CACNA1A CACNA1E ANKFY1 P2RX7 FARP1 NAT10 PDE4DIP SLC4A4 | 5.79e-06 | 963 | 286 | 23 | 28671696 | |
| Pubmed | MYO5A NAGLU PTPN1 PTPN9 UBA1 PTPRB TTC7B PI4KA KCNMA1 KIF14 CKAP4 RELCH ST7 BAG5 XPO4 RNF213 SMPD4 NCOA5 CNNM3 IPO9 NUP155 FARP1 NAT10 EFR3B | 7.40e-06 | 1049 | 286 | 24 | 27880917 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | GBF1 NCKAP1 CACNA2D2 EDC4 CMYA5 NDUFS3 IQGAP1 PIK3R4 WDR3 PTPN1 URB1 UBA1 SARS1 PI4KA EIF3L KIF14 CKAP4 MYO18B ALDOC ANKFY1 POLR1A LBR THOC2 TFRC NCOA5 IPO9 NUP155 GTF3C2 NAT10 | 7.75e-06 | 1425 | 286 | 29 | 30948266 |
| Pubmed | PTPN1 LMF2 CKAP4 UBE2J1 ST7 BAG5 GPAT3 SMPD4 LBR NUP155 GUCY1B1 FARP1 | 8.00e-06 | 299 | 286 | 12 | 37931956 | |
| Pubmed | GBF1 NCKAP1 SARS1 PSME4 PI4KA EIF3L ALDOC ANKFY1 RNF213 IPO9 NUP155 LRBA | 9.45e-06 | 304 | 286 | 12 | 32235678 | |
| Pubmed | 9.80e-06 | 17 | 286 | 4 | 16472605 | ||
| Pubmed | 1.08e-05 | 6 | 286 | 3 | 33317583 | ||
| Pubmed | LPA1 , LPA2 , LPA4 , and LPA6 receptor expression during mouse brain development. | 1.08e-05 | 6 | 286 | 3 | 30847983 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | GBF1 NCKAP1 TSC2 EDC4 TRIP12 LYST PIK3R4 DLC1 PIK3C2A PI4KA KIF14 FNIP1 CARMIL1 SAMD4B LBR ARFGEF3 VPS13D IPO9 DCP1B ELMO2 PLEKHA2 | 1.09e-05 | 861 | 286 | 21 | 36931259 |
| Pubmed | FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells. | 1.15e-05 | 212 | 286 | 10 | 33462405 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | TOPAZ1 NAGLU TSC2 ARHGAP11A TRIP12 NDUFS3 ADRA1D URB1 SARS1 PI4KA AGL EIF3L DSE CACNA1F LAMB4 RNF213 DENND6A CCDC87 CFAP44 | 1.32e-05 | 736 | 286 | 19 | 29676528 |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 1.46e-05 | 38 | 286 | 5 | 30786075 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | MYO5A EDC4 PLD3 TRIP12 NDUFS3 IQGAP1 WDR3 URB1 UBA1 PI4KA KIF14 CKAP4 POLR1A LBR THOC2 TFRC NCOA5 CNNM3 NUP155 EXD2 NAT10 PCBP2 XPO7 | 1.54e-05 | 1024 | 286 | 23 | 24711643 |
| Pubmed | PDE7A MYO5A PLD3 NDUFS3 DMXL1 WDR3 PTPN1 URB1 SARS1 PIK3C2A PI4KA SEMA6A CKAP4 UBE2J1 ST7 BAG5 GPAT3 SMPD4 LBR TFRC CNNM3 CDK5RAP3 NUP155 GTF3C2 MRPS2 FARP1 NAT10 EFR3B ESPL1 | 1.71e-05 | 1487 | 286 | 29 | 33957083 | |
| Pubmed | 1.88e-05 | 7 | 286 | 3 | 22229870 | ||
| Pubmed | Modeled changes of cerebellar activity in mutant mice are predictive of their learning impairments. | 1.88e-05 | 7 | 286 | 3 | 27805050 | |
| Pubmed | 1.88e-05 | 7 | 286 | 3 | 20194452 | ||
| Pubmed | LPA2 promotes neuronal differentiation and neurite formation in neocortical development. | 1.88e-05 | 7 | 286 | 3 | 35151977 | |
| Pubmed | REPS1 NCKAP1 EDC4 NDUFS3 IQGAP1 WDR3 PTPN9 ANAPC5 CUL4B COG2 UBA2 CDK5RAP3 IPO9 NUP155 GTF3C2 ELMO2 | 1.91e-05 | 560 | 286 | 16 | 35241646 | |
| Pubmed | 2.99e-05 | 8 | 286 | 3 | 28330839 | ||
| Pubmed | NCKAP1 MYO5A EDC4 TRIP12 IQGAP1 WDR3 URB1 EIF3L KIF14 CUL4B POLR1A TUT7 USP24 THOC2 NUP155 NAT10 XPO7 | 3.41e-05 | 653 | 286 | 17 | 22586326 | |
| Pubmed | 3.67e-05 | 75 | 286 | 6 | 2834384 | ||
| Pubmed | FAM105A/OTULINL Is a Pseudodeubiquitinase of the OTU-Class that Localizes to the ER Membrane. | PLD3 NDUFS3 PTPN1 YIF1A LMF2 CKAP4 UBE2J1 ST7 GPAT3 SMPD4 LBR CNNM3 CDK5RAP3 NUP155 | 3.87e-05 | 468 | 286 | 14 | 31056421 |
| Pubmed | 4.46e-05 | 9 | 286 | 3 | 26362633 | ||
| Pubmed | 4.46e-05 | 9 | 286 | 3 | 19015308 | ||
| Pubmed | 4.46e-05 | 9 | 286 | 3 | 12907755 | ||
| Pubmed | 4.46e-05 | 9 | 286 | 3 | 20977567 | ||
| Pubmed | 4.46e-05 | 9 | 286 | 3 | 24091496 | ||
| Pubmed | 4.54e-05 | 200 | 286 | 9 | 18240029 | ||
| Pubmed | EFCAB5 ABCC4 TRIP12 IQGAP1 UBA1 NUP37 EIF3L ANAPC5 CUL4B LZTFL1 USP24 UBA2 LBR TFRC RNF170 PPP2R2C IPO9 NUP155 LRBA PCBP2 | 4.61e-05 | 878 | 286 | 20 | 37223481 | |
| Pubmed | 5.68e-05 | 81 | 286 | 6 | 22723691 | ||
| Pubmed | 6.33e-05 | 10 | 286 | 3 | 9328433 | ||
| Pubmed | 6.33e-05 | 10 | 286 | 3 | 20227302 | ||
| Pubmed | [Expression of toll-like receptors in human epidermal keratinocytes]. | 6.33e-05 | 10 | 286 | 3 | 18686608 | |
| Pubmed | A novel protein LZTFL1 regulates ciliary trafficking of the BBSome and Smoothened. | 6.33e-05 | 10 | 286 | 3 | 22072986 | |
| Pubmed | 6.33e-05 | 10 | 286 | 3 | 11782555 | ||
| Pubmed | Tulp3 Regulates Renal Cystogenesis by Trafficking of Cystoproteins to Cilia. | 6.33e-05 | 10 | 286 | 3 | 30799239 | |
| Pubmed | A family of human receptors structurally related to Drosophila Toll. | 6.33e-05 | 10 | 286 | 3 | 9435236 | |
| Pubmed | Interstitial microRNA miR-214 attenuates inflammation and polycystic kidney disease progression. | 6.33e-05 | 10 | 286 | 3 | 32182218 | |
| Pubmed | Lysophosphatidic acid induces neurite branch formation through LPA3. | 6.33e-05 | 10 | 286 | 3 | 22465231 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | TMEM67 ABCC4 MANBA NAGLU TSC2 PLD3 ADGRE2 LRP1B DMXL1 UBA1 LMF2 PKD2 CKAP4 DSE GLIPR1 UBE2J1 TUT7 RNF213 LBR TFRC RNF170 MST1R CNNM3 SERPINE1 | 6.45e-05 | 1201 | 286 | 24 | 35696571 |
| Pubmed | 6.74e-05 | 2 | 286 | 2 | 35012455 | ||
| Pubmed | Role of genetic variation in regulation of aldosterone biosynthesis. | 6.74e-05 | 2 | 286 | 2 | 21164264 | |
| Pubmed | 6.74e-05 | 2 | 286 | 2 | 34884741 | ||
| Pubmed | TLR4 promotes B cell maturation: independence and cooperation with B lymphocyte-activating factor. | 6.74e-05 | 2 | 286 | 2 | 20357250 | |
| Pubmed | Inhibition of the P2X7-PANX1 complex suppresses spreading depolarization and neuroinflammation. | 6.74e-05 | 2 | 286 | 2 | 28430869 | |
| Pubmed | 6.74e-05 | 2 | 286 | 2 | 20634641 | ||
| Pubmed | 6.74e-05 | 2 | 286 | 2 | 39467628 | ||
| Pubmed | Toll-like receptors 4 and 5 induce distinct types of vasculitis. | 6.74e-05 | 2 | 286 | 2 | 19150884 | |
| Pubmed | 6.74e-05 | 2 | 286 | 2 | 15843568 | ||
| Pubmed | 6.74e-05 | 2 | 286 | 2 | 1741400 | ||
| Pubmed | 6.74e-05 | 2 | 286 | 2 | 27418245 | ||
| Pubmed | Voltage-Gated Cav1 Channels in Disorders of Vision and Hearing. | 6.74e-05 | 2 | 286 | 2 | 25966695 | |
| Pubmed | 6.74e-05 | 2 | 286 | 2 | 27323329 | ||
| Pubmed | 6.74e-05 | 2 | 286 | 2 | 22933298 | ||
| Pubmed | 6.74e-05 | 2 | 286 | 2 | 25797291 | ||
| Pubmed | 6.74e-05 | 2 | 286 | 2 | 26819479 | ||
| Pubmed | Molecular genetic studies on the biosynthesis of aldosterone in humans. | 6.74e-05 | 2 | 286 | 2 | 22217843 | |
| Pubmed | Ca1.2 and CaV1.3 neuronal L-type calcium channels: differential targeting and signaling to pCREB. | 6.74e-05 | 2 | 286 | 2 | 16706838 | |
| Pubmed | Elevated methylation of OPRM1 and OPRL1 genes in Alzheimer's disease. | 6.74e-05 | 2 | 286 | 2 | 30152845 | |
| Pubmed | 6.74e-05 | 2 | 286 | 2 | 23761887 | ||
| Pubmed | 6.74e-05 | 2 | 286 | 2 | 14981074 | ||
| Pubmed | [123 I]Iodometomidate for molecular imaging of adrenocortical cytochrome P450 family 11B enzymes. | 6.74e-05 | 2 | 286 | 2 | 18397978 | |
| Pubmed | 6.74e-05 | 2 | 286 | 2 | 12606379 | ||
| Pubmed | 6.74e-05 | 2 | 286 | 2 | 22132188 | ||
| Pubmed | 6.74e-05 | 2 | 286 | 2 | 29449551 | ||
| Pubmed | 6.74e-05 | 2 | 286 | 2 | 23761669 | ||
| Pubmed | 6.74e-05 | 2 | 286 | 2 | 23988121 | ||
| Pubmed | 6.74e-05 | 2 | 286 | 2 | 30904354 | ||
| Pubmed | 6.74e-05 | 2 | 286 | 2 | 24470632 | ||
| Interaction | GPR182 interactions | PI4K2B GBF1 NCKAP1 TSC2 PIK3R4 FANCG URB1 PIK3C2A PI4KA ABCD1 UBE2J1 COG2 RELCH POLG USP24 GPAT3 RNF213 SMPD4 ARFGEF3 LIPE PRAME XPO7 | 3.72e-07 | 455 | 277 | 22 | int:GPR182 |
| Interaction | C3orf18 interactions | 4.29e-06 | 115 | 277 | 10 | int:C3orf18 | |
| Interaction | TNFSF13B interactions | TSC2 MAP3K5 KIF14 FAM118A XPO4 TFRC ARFGEF3 IPO9 NUP155 TNFSF13B | 5.83e-06 | 119 | 277 | 10 | int:TNFSF13B |
| Interaction | NPTN interactions | GBF1 TSC2 EDC4 FANCG PI4KA KIF14 ALDOC COG2 USP24 XPO4 RNF213 ARFGEF3 RANBP17 PRAME XPO7 | 7.65e-06 | 278 | 277 | 15 | int:NPTN |
| Interaction | TMEM17 interactions | NCKAP1 PLD3 NDUFS3 PTPN1 YIF1A SEMA6A CKAP4 UBE2J1 GPAT3 TMEM138 SMPD4 LBR TFRC AP4E1 CNNM3 NUP155 EFR3B LRBA | 1.34e-05 | 404 | 277 | 18 | int:TMEM17 |
| Interaction | CYP11B1 interactions | 2.52e-05 | 5 | 277 | 3 | int:CYP11B1 | |
| Interaction | EVC2 interactions | 2.86e-05 | 88 | 277 | 8 | int:EVC2 | |
| Interaction | LNPK interactions | TMEM67 PTPN1 YIF1A LMF2 AGL CKAP4 CNGA3 UBE2J1 ST7 USP24 GPAT3 SMPD4 LBR CDK5RAP3 NUP155 LPAR2 | 3.54e-05 | 355 | 277 | 16 | int:LNPK |
| Interaction | FPR1 interactions | 3.72e-05 | 147 | 277 | 10 | int:FPR1 | |
| Interaction | RAB7A interactions | SECISBP2L ABCC4 GBF1 TSC2 LYST DMXL1 PIK3R4 PTPN1 PI4KA KIF14 FNIP1 ABCD1 CKAP4 RIC1 UBE2J1 COG2 ANKFY1 ST7 GPAT3 LBR TFRC ARFGEF3 VPS13D CDK5RAP3 NUP155 EXD2 PLEKHA2 LRBA | 3.85e-05 | 886 | 277 | 28 | int:RAB7A |
| Interaction | PACC1 interactions | 3.98e-05 | 119 | 277 | 9 | int:PACC1 | |
| Interaction | GPR17 interactions | TSPAN15 GBF1 TSC2 PIK3R4 FANCG URB1 COG2 USP24 XPO4 RNF213 RNF170 ARFGEF3 LRBA XPO7 | 4.02e-05 | 283 | 277 | 14 | int:GPR17 |
| Interaction | TMT1A interactions | GBF1 PLD3 PTPN1 PTPN9 LMF2 CKAP4 UBE2J1 ST7 GPAT3 SMPD4 LBR TFRC CNNM3 CDK5RAP3 NUP155 LRBA | 4.05e-05 | 359 | 277 | 16 | int:TMT1A |
| Interaction | LMBR1L interactions | NCKAP1 TSC2 EDC4 PLD3 TRIP12 NDUFS3 IQGAP1 YIF1A URB1 LMF2 SARS1 PI4KA EIF3L ABCD1 CKAP4 ANAPC5 POLR1A TUT7 USP24 LBR TFRC RNF170 ARFGEF3 CNNM3 IPO9 NUP155 EXD2 ESPL1 XPO7 | 4.80e-05 | 946 | 277 | 29 | int:LMBR1L |
| Interaction | B3GAT1 interactions | GBF1 PLD3 PTPN1 YIF1A LMF2 CKAP4 RIC1 UBE2J1 USP24 GPAT3 SMPD4 LBR TFRC CDK5RAP3 FARP1 LRBA | 7.23e-05 | 377 | 277 | 16 | int:B3GAT1 |
| Interaction | RAB9A interactions | MYO5A TSC2 DMXL1 PIK3R4 PTPN1 LMF2 PI4KA CKAP4 UBE2J1 RELCH ARRDC4 GPAT3 SMPD4 LBR TFRC ARFGEF3 VPS13D CDK5RAP3 DENND6A NUP155 LRBA | 8.16e-05 | 595 | 277 | 21 | int:RAB9A |
| Interaction | IFITM5 interactions | 8.63e-05 | 7 | 277 | 3 | int:IFITM5 | |
| GeneFamily | Calcium voltage-gated channel subunits | 3.55e-07 | 26 | 203 | 6 | 253 | |
| GeneFamily | Lysophosphatidic acid receptors | 2.72e-05 | 6 | 203 | 3 | 205 | |
| GeneFamily | WD repeat domain containing | LYST DMXL1 PIK3R4 WDR3 NUP37 CFAP43 DENND3 PPP2R2C GTF3C2 LRBA MAPKBP1 CFAP44 | 4.23e-05 | 262 | 203 | 12 | 362 |
| GeneFamily | Prokineticin receptors | 1.25e-04 | 2 | 203 | 2 | 216 | |
| GeneFamily | CD molecules|Toll like receptors | 1.58e-04 | 10 | 203 | 3 | 948 | |
| GeneFamily | Cytochrome P450 family 11 | 3.74e-04 | 3 | 203 | 2 | 1007 | |
| GeneFamily | Opioid receptors | 7.42e-04 | 4 | 203 | 2 | 245 | |
| GeneFamily | Dyneins, axonemal | 8.44e-04 | 17 | 203 | 3 | 536 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 2.37e-03 | 50 | 203 | 4 | 721 | |
| GeneFamily | Exportins | 2.54e-03 | 7 | 203 | 2 | 547 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 2.67e-03 | 25 | 203 | 3 | 504 | |
| Coexpression | DESCARTES_ORGANOGENESIS_WHITE_BLOOD_CELLS | STARD8 MANBA MYO5A ITGAM CCDC88B MAP3K5 IQGAP1 FANCG SNX8 ABCD1 DSE GLIPR1 ENGASE MRC1 ARMC7 GPR34 UGT1A10 RNF213 SLC17A5 CRYL1 LIPE MCTP1 P2RX7 TLR4 PLEKHA2 CARD11 NCKAP1L | 9.09e-10 | 615 | 284 | 27 | MM3641 |
| Coexpression | WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP | MANBA MYO5A ERV3-1 NAGLU PLD3 DMXL1 AGL CACNA1E GPAT3 RNF213 SLC17A5 CDK5RAP3 DCP1B KIAA0825 TNFSF13B LPAR2 | 6.77e-06 | 392 | 284 | 16 | M2131 |
| Coexpression | GSE17721_CTRL_VS_LPS_12H_BMDC_UP | CMYA5 PIK3C2A AGL HPF1 ABCD1 GLIPR1 MRC1 CACNA1F KCNK13 G6PC1 LARGE1 | 1.21e-05 | 199 | 284 | 11 | M3701 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | SECISBP2L STARD8 CHAC2 USP25 JADE1 ADGRE2 LYST TENM2 DMXL1 PTPRB ARHGAP29 MED13 LPAR4 TUT7 LZTFL1 CCRL2 SEMA5A PREX2 ARFGEF3 SLC17A5 AP4E1 DENND6A PDE4DIP TLR4 LRBA | 1.46e-05 | 888 | 284 | 25 | MM1018 |
| Coexpression | PARENT_MTOR_SIGNALING_UP | TRADD GBF1 TSC2 MAP3K5 IQGAP1 FANCG PI4KA POLG SLC17A5 CRYL1 NPRL2 VPS13D CDK5RAP3 FARP1 SLIT1 PDE4DIP SLC4A4 PCBP2 NCKAP1L | 1.57e-05 | 567 | 284 | 19 | M16909 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HMGL | MANBA LYST MAP3K5 NUP37 KIF14 GLIPR1 MRC1 GPR34 RNF213 CCRL2 KCNK13 DENND3 MCTP1 LPAR6 TLR4 CARD11 SLC4A4 TMEM19 NCKAP1L | 1.99e-05 | 577 | 284 | 19 | M39051 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | SECISBP2L STARD8 CHAC2 USP25 JADE1 LYST TENM2 DMXL1 PTPRB ARHGAP29 MED13 LPAR4 TUT7 LZTFL1 CCRL2 SEMA5A PREX2 ARFGEF3 SLC17A5 AP4E1 DENND6A PDE4DIP TLR4 LRBA | 2.24e-05 | 854 | 284 | 24 | M1533 |
| Coexpression | GSE4984_UNTREATED_VS_VEHICLE_CTRL_TREATED_DC_UP | 5.13e-05 | 155 | 284 | 9 | M6500 | |
| Coexpression | ZENG_GU_POST_ICB_METAGENE_41 | TRMT10B PDE7A CENPL EIF3L LZTFL1 RANBP17 CNNM3 DENND6A IPO9 IFT88 | 5.68e-05 | 195 | 284 | 10 | MM17091 |
| Coexpression | GSE36009_WT_VS_NLRP10_KO_DC_LPS_STIM_DN | PI4K2B MYO5A CHAC2 PTPRB PSME4 DSE SMPD4 VPS13D PLEKHA2 TMC5 | 6.73e-05 | 199 | 284 | 10 | M8770 |
| Coexpression | GSE7348_UNSTIM_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_DN | 6.89e-05 | 161 | 284 | 9 | M6848 | |
| Coexpression | GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_DN | ADGRE2 ITGAM SLC8B1 PI4KA CKAP4 DSE CARMIL1 LPAR6 PDE4DIP SERPINE1 | 7.02e-05 | 200 | 284 | 10 | M4624 |
| Coexpression | GSE15767_MED_VS_SCS_MAC_LN_UP | 7.02e-05 | 200 | 284 | 10 | M3584 | |
| Coexpression | FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON | STK36 ABCC8 KCNMA1 CACNA1A CACNA1C CACNA1E RNF213 ARFGEF3 TNK2 | 8.72e-05 | 166 | 284 | 9 | M39026 |
| Coexpression | SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP | 8.80e-05 | 67 | 284 | 6 | M3695 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | ABCC4 TNFRSF9 GBF1 LYST IQGAP1 URB1 ANKFY1 XPO4 RNF213 LBR TFRC ZNF708 NUP155 LRBA | 2.84e-11 | 191 | 286 | 14 | 9454f642c3621370fa23640b631301346b300950 |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | ABCC4 GBF1 URB1 KIF14 ANKFY1 RNF213 LBR TFRC ZNF708 NUP155 LRBA | 3.42e-08 | 185 | 286 | 11 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | ABCC4 GBF1 URB1 KIF14 ANKFY1 RNF213 LBR TFRC ZNF708 NUP155 LRBA | 3.61e-08 | 186 | 286 | 11 | 8571956890fc9894d766ba294a28e376b4aba428 |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | MYO5A ITGAM GLIPR1 MRC1 GPR34 DENND3 TFRC LPAR6 TLR4 LTC4S NCKAP1L | 4.03e-08 | 188 | 286 | 11 | cb091912f9b627a78a8793a37df7f1de839f887f |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|lung / Disease (COVID-19 only), tissue and cell type | MANBA MYO5A ADGRE2 ITGAM KCNMA1 MRC1 KCNK13 TFRC MCTP1 P2RX7 NCKAP1L | 5.86e-08 | 195 | 286 | 11 | 148fff8c3c9ba45ec36e98dff1be57e3f8294506 |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|lung / Disease (COVID-19 only), tissue and cell type | MANBA MYO5A ADGRE2 ITGAM KCNMA1 MRC1 KCNK13 TFRC MCTP1 P2RX7 NCKAP1L | 6.50e-08 | 197 | 286 | 11 | 3896729740d151f0eb845f1961c7b969bfbdd28d |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | MYO5A ADGRE2 GLIPR1 MRC1 GPR34 RNF213 DENND3 TFRC LPAR6 TLR4 NCKAP1L | 7.21e-08 | 199 | 286 | 11 | 5ceeed92f831d068ff4bb3994f420002338330e7 |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | ABCC4 ITGAM ACSM5 MRC1 GPR34 LPAR6 TLR4 CARD11 LTC4S NCKAP1L | 3.68e-07 | 186 | 286 | 10 | e41f14aee8cfbf76b8d0d4695a6170e2cd92aec8 |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Endothelial_Myeloid-Micro|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | ABCC4 ITGAM ACSM5 MRC1 GPR34 LPAR6 TLR4 CARD11 LTC4S NCKAP1L | 3.68e-07 | 186 | 286 | 10 | 9dd31dc9af1704f35c74de726a6c27fa21e9a014 |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia-Micro_L1-6_C1QC|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | ABCC4 ITGAM ACSM5 MRC1 GPR34 LPAR6 TLR4 CARD11 LTC4S NCKAP1L | 3.68e-07 | 186 | 286 | 10 | b3633cd4e360c5b45060c50b4f606d483e03a89a |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | CMTR1 KCNMA1 ANAPC5 CACNA1C RELCH PCDHGB5 USP24 LBR SLC17A5 LARGE1 | 4.06e-07 | 188 | 286 | 10 | 6468fa95ad0395395301115286f2d8c0df5d3882 |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | CMTR1 KCNMA1 ANAPC5 CACNA1C RELCH PCDHGB5 USP24 LBR SLC17A5 LARGE1 | 4.06e-07 | 188 | 286 | 10 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | CMTR1 KCNMA1 ANAPC5 CACNA1C RELCH PCDHGB5 USP24 LBR SLC17A5 LARGE1 | 4.06e-07 | 188 | 286 | 10 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage2_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | ADGRE2 ITGAM TLR8 GLIPR1 MRC1 GPR34 CCRL2 MCTP1 P2RX7 NCKAP1L | 4.70e-07 | 191 | 286 | 10 | 09dfad8e1fcaaf94775134796b99e4e3fbb9bf40 |
| ToppCell | COVID-19-lung-Macrophage_PPARGhi_CD5Lhi|lung / Disease (COVID-19 only), tissue and cell type | MANBA MYO5A KCNMA1 MRC1 ARRDC4 SLC19A3 TFRC P2RX7 PDE4DIP NCKAP1L | 4.70e-07 | 191 | 286 | 10 | dab953682b8c9ed680a799161f837f792a7e4f33 |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | SECISBP2L ABCC4 CACNA2D2 ADGRV1 DLC1 ST7 CARMIL1 ARFGEF3 SLC4A4 LARGE1 | 5.42e-07 | 194 | 286 | 10 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | ADGRE2 ITGAM SLC8B1 SNX8 GPAT3 KCNK13 TFRC MCTP1 TNFSF13B NCKAP1L | 5.42e-07 | 194 | 286 | 10 | 3043f6230fa723037c8cf7123f611ae847b39fd4 |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | ITGAM GLIPR1 MRC1 GPR34 DENND3 TFRC LPAR6 TLR4 LTC4S NCKAP1L | 5.68e-07 | 195 | 286 | 10 | 028622b234551b185977fbee10c06851a45456a5 |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | MANBA MYO5A ADGRE2 ITGAM KCNMA1 MRC1 KCNK13 TFRC P2RX7 NCKAP1L | 5.95e-07 | 196 | 286 | 10 | 7026c1fc33425e5476063d17c79e4b79356a9e01 |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | ITGAM TLR8 KCNMA1 GLIPR1 MRC1 GPR34 LPAR6 TNFSF13B TLR4 NCKAP1L | 6.23e-07 | 197 | 286 | 10 | 2efb5acd56b96e5afd8d72b927f1d53cc443766f |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | MANBA ADGRE2 ITGAM CCDC88B KCNMA1 MRC1 RNF213 MCTP1 P2RX7 NCKAP1L | 6.23e-07 | 197 | 286 | 10 | e42910a653a1b5bd90c090e9665a84871ed2873f |
| ToppCell | COVID-19-Myeloid|COVID-19 / group, cell type (main and fine annotations) | 6.53e-07 | 198 | 286 | 10 | 33f0a919188a67d2a876b52c61a1cec2c9747969 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Myeloid-Microglia|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 6.84e-07 | 199 | 286 | 10 | 4ddfbcaa8054b69b3398d8c0d5fab8ae94805cb9 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | MYO5A ADGRE2 GLIPR1 MRC1 GPR34 DENND3 TFRC LPAR6 TLR4 NCKAP1L | 6.84e-07 | 199 | 286 | 10 | f34c15df58fbdc6c90e30800e26fabbf828ad10b |
| ToppCell | cellseq2-Immune-Immune_Myeloid|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | ADGRE2 ITGAM TLR8 DSE MRC1 GPR34 P2RX7 TNFSF13B TLR4 NCKAP1L | 6.84e-07 | 199 | 286 | 10 | 6c3c9eceea20121ae17ae2462134aa0437f591b3 |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Myeloid|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 6.84e-07 | 199 | 286 | 10 | 3ba48a4715d5e9387650aa97e0c5d7f7897bf380 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Myeloid-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ARHGAP11A ITGAM CACNA1C MRC1 CACNA1F SMPD4 KCNK13 TLR5 NCKAP1L | 1.08e-06 | 162 | 286 | 9 | 71d7849108a1b59beff40e46000172c45a2f5439 |
| ToppCell | facs-MAT-Fat-3m-Myeloid-myeloid_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-06 | 163 | 286 | 9 | 5fc836444bc156c8248abee001b0ecbe43f980c9 | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-endothelial_cells_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.14e-06 | 163 | 286 | 9 | d6f9b7280c44d120df5a72dfc2ebb26ffbb5752b | |
| ToppCell | droplet-Heart-HEART-1m-Hematologic-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-06 | 127 | 286 | 8 | 983489a69d3b1f1fe21110a862ac1dba53e9d31c | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-CD1c+_DCs|Myeloid_cells / Location, Cell class and cell subclass | TSPAN15 TNFRSF9 SEPTIN1 REC8 CACNA1C NAALADL1 CARMIL1 CARD11 LRBA | 2.70e-06 | 181 | 286 | 9 | cc7ae1221a28bc404138a7efee0ad08a19cc3d86 |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TSPAN15 PTPRB PIK3C2A ARHGAP29 SEMA6A PREX2 LIPE LPAR6 SLC28A2 | 2.83e-06 | 182 | 286 | 9 | 81279877b920b5a1bc991a07d3031d6458700fe3 |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.83e-06 | 182 | 286 | 9 | de15a77b8d3527638bea5b04e0b2af03ac93bc18 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-Macrophages|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.83e-06 | 182 | 286 | 9 | ea39b1b5db185b0cb11dfa2e01f3f972effbd770 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.09e-06 | 184 | 286 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.09e-06 | 184 | 286 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.09e-06 | 184 | 286 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | BAL-Severe-Myeloid-Macrophage|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.24e-06 | 185 | 286 | 9 | ae966929fb5bbb08ffcbac76cb21941638727f55 | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.24e-06 | 185 | 286 | 9 | 3beebaa92275086b1fae5f8c0c3d54016c5ba2aa | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.24e-06 | 185 | 286 | 9 | 42939b294ea3e871274d8b73124c850dc1904fd2 | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.24e-06 | 185 | 286 | 9 | 7a3612520ae4f0cd61480eadba31eecce001419d | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.24e-06 | 185 | 286 | 9 | ceff11cfa679147ccfd0a0f8079e697a6bea34d9 | |
| ToppCell | BAL-Severe-Myeloid-Macrophage|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.24e-06 | 185 | 286 | 9 | 9aea5ed8f9cee5ee933891203aac7adb85d68201 | |
| ToppCell | Severe_COVID-19-Myeloid-transitional_Macro|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 3.24e-06 | 185 | 286 | 9 | f7ef0d7740b4cfedc38846e802898c402dc411fd | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.38e-06 | 186 | 286 | 9 | 02418c50fdcca549bf73dedf6199ab4a27862a9b | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.38e-06 | 186 | 286 | 9 | 39e475a3c167b33daa63b0c1bfa32451c5f46635 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Endothelial_Myeloid|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.53e-06 | 187 | 286 | 9 | 23a42c172d5cc36cb8793c0bc2ce357c6c8e5d39 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 3.53e-06 | 187 | 286 | 9 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.69e-06 | 188 | 286 | 9 | 3be2d50148daa4eddddc2c7f269f45c97f7e4931 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.69e-06 | 188 | 286 | 9 | 5df5a0890e17d19f55770525345a656253696887 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia-Micro_L1-6_C1QC|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.69e-06 | 188 | 286 | 9 | 9e923b0d79495ee1a3a097741a877f25d439eda3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Endothelial_Myeloid-Micro|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.69e-06 | 188 | 286 | 9 | 14dbc985abc2012c9f53deb243d465e4175f419f | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.69e-06 | 188 | 286 | 9 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Endothelial_Myeloid|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.85e-06 | 189 | 286 | 9 | e9fe8d17f4b7cca9bbf3655047e27b2fec5060c1 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid-Micro|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.85e-06 | 189 | 286 | 9 | 7ac78441a15a82218deaafd47accff2ea5c8de20 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia-Micro_L1-6_C1QC|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.85e-06 | 189 | 286 | 9 | 389ccb68acb82893709f256315111470cf4beed3 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.85e-06 | 189 | 286 | 9 | 58465b9407fbce91cca8f199950d6e0054c38fbc | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.02e-06 | 190 | 286 | 9 | d4f954e0748898df69e1710df558564db703dd61 | |
| ToppCell | COVID-19-lung-Vein_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | LYST PTPRB PIK3C2A ABCC8 ARHGAP29 SEMA6A PREX2 MCTP1 SERPINE1 | 4.02e-06 | 190 | 286 | 9 | 1caeaef78326734c1e31a0c4739190d5c5a77b9e |
| ToppCell | Control-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 4.02e-06 | 190 | 286 | 9 | 4e30155203b4a8c5e496fcbe9348b67b98ebc625 | |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | 4.38e-06 | 192 | 286 | 9 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | SECISBP2L ABCC4 CACNA2D2 ADGRV1 DLC1 ARFGEF3 SLC4A4 TMC5 LARGE1 | 4.57e-06 | 193 | 286 | 9 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | SECISBP2L ABCC4 CACNA2D2 ADGRV1 DLC1 ARFGEF3 SLC4A4 TMC5 LARGE1 | 4.57e-06 | 193 | 286 | 9 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf |
| ToppCell | RA-08._Macrophage|World / Chamber and Cluster_Paper | 4.57e-06 | 193 | 286 | 9 | 5fd22db1825d105709fcc0aa4955c99a117e3c82 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.57e-06 | 193 | 286 | 9 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular-Interstitial_macrophage_perivascular_L.1.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.76e-06 | 194 | 286 | 9 | 7b6a34d1f8922b71dcc931421666c1822cec8345 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 4.76e-06 | 194 | 286 | 9 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.76e-06 | 194 | 286 | 9 | 435406ebe626c702f7d5a99a3d68ee85aa09be95 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.76e-06 | 194 | 286 | 9 | 48c37251518f96524807b5bd1bbc2820637666ad | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.76e-06 | 194 | 286 | 9 | c95d5c4ad0210ebd672926558cc8331e6396a854 | |
| ToppCell | RA-08._Macrophage|RA / Chamber and Cluster_Paper | 4.76e-06 | 194 | 286 | 9 | ac26e5c71d5069622de72fa25a9c920887ac2c19 | |
| ToppCell | 367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.97e-06 | 195 | 286 | 9 | 4008fa86b5166087a4b20f89ae07e1dfc87c855d | |
| ToppCell | PCW_10-12-Hematologic_Myeloid|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.97e-06 | 195 | 286 | 9 | 6352cd749091cfdbf5cce3c354fa57883cc513e8 | |
| ToppCell | B_cells-ISG-high_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | SECISBP2L PI4K2B CMTR1 USP25 DMXL1 CACNA1A ANKFY1 RNF213 TNFSF13B | 4.97e-06 | 195 | 286 | 9 | b64d9e1a8834401b4dc501566546647754ae21fc |
| ToppCell | Monocytes-IL1B+_Monocytes|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 5.18e-06 | 196 | 286 | 9 | 7bc0735d324ac5a1661434cda4116ddd58296730 | |
| ToppCell | COVID-19-lung-Macrophage_metabolically_active|lung / Disease (COVID-19 only), tissue and cell type | 5.18e-06 | 196 | 286 | 9 | a753d76d764c181eecb0e17a794a2e7d0ff70136 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.40e-06 | 197 | 286 | 9 | 10190b877bf46ba2163d203df9dd3b498c66e52f | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.62e-06 | 198 | 286 | 9 | dbae6a58cb3ce8612755fbdba6194b70b35f258a | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | SECISBP2L CACNA2D2 ADGRV1 ST7 ARFGEF3 RANBP17 FARP1 SLC4A4 TMC5 | 5.86e-06 | 199 | 286 | 9 | 5f7da3eab58ace6cddb3179a415cd839d5767958 |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.86e-06 | 199 | 286 | 9 | 9df2c79904dacf029ec9df1f1cde72d871189a82 | |
| ToppCell | cellseq2-Immune-Immune_Myeloid-IM-IM|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.86e-06 | 199 | 286 | 9 | 372fb9eb90022dc4ac770a75b4e207c33d1d0c43 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.86e-06 | 199 | 286 | 9 | ca0f6526ba0dcf8789dd3b583291519626427f2f | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.86e-06 | 199 | 286 | 9 | e1066e638af83ba5e89c7cabb8ad00b6bcdee5f4 | |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.86e-06 | 199 | 286 | 9 | 22001aa733273e784051b7f750e07d99aaf7a225 | |
| ToppCell | cellseq2-Immune-Immune_Myeloid-IM|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.86e-06 | 199 | 286 | 9 | dd3bf59cdc18091889cbf6c43f37100ba537843d | |
| ToppCell | Parenchyma_COVID-19-Immune-TX-MoAM-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 6.10e-06 | 200 | 286 | 9 | 33c5615cbedb9e14f4433169babd3a3a51f69b4c | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | CACNA2D2 ABCA13 SH3YL1 CFAP43 AQP5 TSPAN1 ARFGEF3 DNAH12 TMC5 | 6.10e-06 | 200 | 286 | 9 | d5426cd318a8f90c0bd8f9804351ab230fafc995 |
| ToppCell | severe-Classical_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.10e-06 | 200 | 286 | 9 | f46689940fdea500ce2457eec412dd2c46705819 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | CACNA2D2 ABCA13 SH3YL1 CFAP43 AQP5 TSPAN1 ARFGEF3 DNAH12 TMC5 | 6.10e-06 | 200 | 286 | 9 | 21d9cf3cd3696ad6b745c7c036798f04b6ce5160 |
| ToppCell | Lung_Parenchyma-Severe-Epithelial|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | CACNA2D2 ABCA13 SH3YL1 CFAP43 AQP5 TSPAN1 ARFGEF3 DNAH12 TMC5 | 6.10e-06 | 200 | 286 | 9 | 33658d5d09e2eaff60f4dd88837d4252328eab63 |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.10e-06 | 200 | 286 | 9 | 78d75d381cb2b9a4c9eb7c32a07b014eaee39195 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.10e-06 | 200 | 286 | 9 | cc3cdfc4636d8892500ce60518c5ccc100b9e5df | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Myeloid-macrophage|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.74e-06 | 153 | 286 | 8 | 4b999892fb797e9f0d391630094f466463299d57 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Myeloid-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.74e-06 | 153 | 286 | 8 | e426db29e4ba83e7930dc88c74fc975b177c9540 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Myeloid|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.74e-06 | 153 | 286 | 8 | 668eacd76aad6054bd7d57e3af0b122c2443465f | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_ALM_Cpa6|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.07e-06 | 154 | 286 | 8 | 12cbc38bc1f7231c67e1d2d5e86e95bc12e24682 | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-2|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.42e-06 | 155 | 286 | 8 | 0fd66c623cb433ceaa893bc21ba2e3b394faaf70 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.02e-05 | 162 | 286 | 8 | 58da6bc04cdac0002b0e6a751c96ff95e1a7f70f | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Ctxn3_Sla|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.02e-05 | 162 | 286 | 8 | 4d13c271b4f63cf32980e5643b5d5951165fe8b5 | |
| ToppCell | droplet-Liver-nan-3m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 164 | 286 | 8 | 950f87d9dacee45c9004a9bf894543de38f72ee5 | |
| Drug | pimozide | CACNA2D2 ADRA1D ABCC8 PKD2 CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F HTR1A OPRL1 OPRM1 | 6.51e-08 | 127 | 283 | 12 | CID000016362 |
| Drug | CNS 1145 | 1.38e-07 | 33 | 283 | 7 | CID000190902 | |
| Drug | IHC-64 | 1.38e-07 | 33 | 283 | 7 | CID000162753 | |
| Drug | isovalerate | STK36 CACNA2D2 TSPYL2 NAGLU PKD2 SEMA6A CACNA1A CACNA1C CACNA1D CACNA1E NCOA5 TBCCD1 | 2.41e-07 | 143 | 283 | 12 | CID000010430 |
| Drug | Dantrolene-13C3 | GALR1 CACNA2D2 PIK3C2A PKD2 CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F GRINA AQP5 LIPE | 2.80e-07 | 145 | 283 | 12 | CID000002951 |
| Drug | Cinildipine | CACNA2D2 PKD2 CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F SERPINE1 | 4.37e-07 | 56 | 283 | 8 | CID000002752 |
| Drug | baclofen | CACNA2D2 PKD2 CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F HTR1A KCNK13 GRINA OPRL1 OPRM1 GABRA6 | 8.53e-07 | 191 | 283 | 13 | CID000002284 |
| Drug | Barium permanganate | CACNA2D2 SLC8B1 ABCC8 KCNMA1 CACNA1A CACNA1C CACNA1D KCNK13 P2RX7 GUCY1B1 CARD11 | 8.89e-07 | 133 | 283 | 11 | CID000024587 |
| Drug | riluzole | CACNA2D2 PTPN1 PKD2 CNTF CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F KCNK13 GRINA GABRA6 | 1.97e-06 | 174 | 283 | 12 | CID000005070 |
| Drug | halothane | CACNA2D2 CYP11B1 CYP11B2 PIK3C2A PKD2 KCNMA1 CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F KCNK13 LBR LIPE LTC4S GABRA6 | 2.24e-06 | 314 | 283 | 16 | CID000003562 |
| Drug | Bay K 8644 | CACNA2D2 CYP11B2 PKD2 CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F HTR1A CALCA LRBA | 2.91e-06 | 150 | 283 | 11 | CID000002303 |
| Drug | isotetrandrine | CACNA2D2 CYP11B2 PKD2 KCNMA1 CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F | 3.43e-06 | 97 | 283 | 9 | CID000005422 |
| Drug | noradrealine | CACNA2D2 ADRA1D PIK3C2A ABCC8 PKD2 CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F HTR1A CALCA LPAR4 AQP2 TSPAN1 OPRL1 OPRM1 SLC17A5 LIPE P2RX7 LRBA SLC4A4 | 3.48e-06 | 575 | 283 | 22 | CID000000951 |
| Drug | isradipine | CACNA2D2 PKD2 KCNMA1 CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F SEMA5A | 4.42e-06 | 100 | 283 | 9 | CID000003784 |
| Drug | mercury | ABCC4 CACNA2D2 CYP11B1 CYP11B2 NAGLU PIK3R4 PIK3C2A PKD2 PACS2 ENGASE CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F CALCA AQP2 AQP5 SERPINE1 CARD11 GABRA6 | 4.81e-06 | 542 | 283 | 21 | CID000023931 |
| Drug | AC1L1DXE | CACNA2D2 PROKR1 PROKR2 PIK3C2A PKD2 CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F HTR1A CALCA GRINA OPRL1 OPRM1 | 5.63e-06 | 299 | 283 | 15 | CID000002548 |
| Drug | loperamide | CACNA2D2 PKD2 CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F OPRL1 OPRM1 | 6.61e-06 | 105 | 283 | 9 | CID000003954 |
| Drug | tetradotoxin | GALR1 ITIH4 ADRA1D KCNMA1 CACNA1A CACNA1C CACNA1D CACNA1E HTR1A CALCA LPAR4 GRINA OPRL1 OPRM1 P2RX7 GUCY1B1 CARD11 GABRA6 | 7.72e-06 | 428 | 283 | 18 | CID000020382 |
| Drug | nilvadipine | 9.36e-06 | 60 | 283 | 7 | CID000004494 | |
| Drug | octylmethoxycinnamate | CACNA2D2 CYP11B1 CYP11B2 TSC2 CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F SLIT1 | 9.77e-06 | 139 | 283 | 10 | ctd:C118580 |
| Drug | lavendustin A | CACNA2D2 PIK3C2A PKD2 KCNMA1 CNGA3 CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F LRBA | 1.03e-05 | 171 | 283 | 11 | CID000003894 |
| Drug | IAA-94 | 1.05e-05 | 61 | 283 | 7 | CID000003667 | |
| Drug | arabinosyladenine | CACNA2D2 PLD3 ADRA1D SARS1 PIK3C2A PI4KA ABCC8 PKD2 KCNMA1 DSE CACNA1A CACNA1C CACNA1D CACNA1E LPAR4 OPRL1 OPRM1 LIPE P2RX7 GUCY1B1 LPAR6 SLC28A2 CARD11 LRBA G6PC1 | 1.10e-05 | 762 | 283 | 25 | CID000000191 |
| Drug | lercanidipine | 1.30e-05 | 63 | 283 | 7 | CID000065866 | |
| Drug | nimodipine | CACNA2D2 PKD2 CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F HTR1A GRINA GABRA6 | 1.42e-05 | 145 | 283 | 10 | CID000004497 |
| Drug | Calcium | MYO5A CACNA2D2 IQGAP1 PROKR1 ADRA1D PKD2 KCNMA1 CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F HTR1A CALCA OPRM1 P2RX7 IFT88 SERPINE1 G6PC1 | 1.48e-05 | 493 | 283 | 19 | ctd:D002118 |
| Drug | lamotrigine | CACNA2D2 PKD2 CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F UGT1A10 GRINA | 1.49e-05 | 116 | 283 | 9 | CID000003878 |
| Drug | AC1NBU2S | CACNA2D2 PKD2 CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F GUCY1B1 CARD11 | 1.60e-05 | 117 | 283 | 9 | CID004473765 |
| Drug | eniluracil | 1.85e-05 | 27 | 283 | 5 | CID000043157 | |
| Drug | AC1NUZ8M | 1.95e-05 | 92 | 283 | 8 | CID000073211 | |
| Drug | gallopamil | 1.96e-05 | 67 | 283 | 7 | CID000001234 | |
| Drug | AC1L2AC7 | 2.38e-05 | 69 | 283 | 7 | CID000068733 | |
| Drug | potassium | GALR1 MYO5A CACNA2D2 CYP11B1 CYP11B2 SLC8B1 PIK3C2A ABCC8 PKD2 KCNMA1 CUL4B CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F HTR1A CALCA KCNK13 GRINA OPRL1 TFRC P2RX7 GUCY1B1 MRPS2 CARD11 LRBA SLC4A4 GABRA6 | 2.53e-05 | 1008 | 283 | 29 | CID000000813 |
| Drug | U-37883A | 2.66e-05 | 29 | 283 | 5 | CID000064392 | |
| Drug | butylparaben | CACNA2D2 CYP11B1 TSC2 CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F GPER1 SLIT1 | 2.82e-05 | 157 | 283 | 10 | ctd:C038091 |
| Drug | Barium | 3.14e-05 | 72 | 283 | 7 | ctd:D001464 | |
| Drug | CAS 298-57-7 | 3.44e-05 | 73 | 283 | 7 | CID000002761 | |
| Drug | 8-bromoguanosine 3',5'-cyclic monophosphate | CACNA2D2 PIK3C2A PKD2 KCNMA1 CNGA3 CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F GUCY1B1 SERPINE1 CARD11 LRBA | 3.45e-05 | 308 | 283 | 14 | CID000001915 |
| Drug | enzacamene | CACNA2D2 CYP11B1 TSC2 CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F SLIT1 | 3.48e-05 | 129 | 283 | 9 | ctd:C038939 |
| Drug | KW-3049 | 3.51e-05 | 50 | 283 | 6 | CID000002324 | |
| Drug | ethosuximide | 3.76e-05 | 74 | 283 | 7 | CID000003291 | |
| Drug | Verapamil | 3.78e-05 | 16 | 283 | 4 | DB00661 | |
| Drug | Diclofenac sodium [15307-79-6]; Down 200; 12.6uM; MCF7; HT_HG-U133A | SERPINA3 MANBA TSC2 SLC8B1 GLIPR1 LZTFL1 METTL25B FARP1 PDE4DIP GREB1 TMC5 | 4.20e-05 | 199 | 283 | 11 | 7215_DN |
| Drug | Succimer | PDE7A NCKAP1 JADE1 PLD3 ITGAM BBS9 MAP3K5 PKD2 ATXN3 MED13 GLIPR1 CACNA1A POLR1A ARRDC4 RNF213 CCRL2 SMPD4 SEMA5A THOC2 TFRC TTC7A ARFGEF3 CNNM3 ZNF430 GTF3C2 GUCY1B1 TNFSF13B PDE4DIP TLR4 SERPINE1 SLC28A2 PCBP2 TPBG | 4.74e-05 | 1264 | 283 | 33 | ctd:D004113 |
| Drug | lanthanum | CACNA2D2 NAGLU PKD2 CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F GPAT3 | 5.27e-05 | 136 | 283 | 9 | CID000023926 |
| Drug | nisoldipine | 5.29e-05 | 78 | 283 | 7 | CID000004499 | |
| Drug | 13-methoxyibogamine | 5.47e-05 | 54 | 283 | 6 | CID000065749 | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 5.75e-05 | 79 | 283 | 7 | CID005287890 | |
| Drug | urushiol | 6.23e-05 | 18 | 283 | 4 | CID005478165 | |
| Drug | umespirone | 6.41e-05 | 7 | 283 | 3 | CID000065902 | |
| Drug | Isradipine | 6.41e-05 | 7 | 283 | 3 | DB00270 | |
| Drug | 2-mercaptoacetate | 6.41e-05 | 7 | 283 | 3 | ctd:C017487 | |
| Drug | guanine | GBF1 GALR1 TSC2 PLD3 SSTR4 TLR8 IQGAP1 ADRA1D TMPRSS11D FGD1 FNIP1 POLK GNL1 CACNA1E HTR1A LPAR4 GRINA NKIRAS1 PREX2 OPRL1 OPRM1 MST1R P2RX7 LPAR6 LRBA XPO7 | 6.54e-05 | 902 | 283 | 26 | CID000000764 |
| Drug | nifedipine | MYO5A CACNA2D2 CYP11B1 CYP11B2 ITIH4 ADRA1D PKD2 KCNMA1 CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F CALCA GRINA LRBA | 6.99e-05 | 415 | 283 | 16 | CID000004485 |
| Drug | Betulinic acid [472-15-1]; Down 200; 8.8uM; HL60; HT_HG-U133A | ITGAM LYST ALDOC ANAPC5 GLIPR1 ANKFY1 POLG TLR4 PLEKHA2 SLC4A4 | 7.44e-05 | 176 | 283 | 10 | 1345_DN |
| Drug | papaverine | CACNA2D2 ABCC8 PKD2 CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F GUCY1B1 CARD11 | 7.44e-05 | 176 | 283 | 10 | CID000004680 |
| Drug | 1-MT | 7.46e-05 | 57 | 283 | 6 | CID000098112 | |
| Drug | etorphine | 9.07e-05 | 59 | 283 | 6 | CID000026721 | |
| Drug | Magnetite Nanoparticles | PDE7A NCKAP1 JADE1 PLD3 ITGAM BBS9 MAP3K5 PKD2 ATXN3 MED13 GLIPR1 CACNA1A POLR1A ARRDC4 RNF213 CCRL2 SMPD4 SEMA5A THOC2 TFRC TTC7A ARFGEF3 CNNM3 ZNF430 GTF3C2 GUCY1B1 TNFSF13B PDE4DIP TLR4 SERPINE1 SLC28A2 PCBP2 TPBG | 9.39e-05 | 1310 | 283 | 33 | ctd:D058185 |
| Drug | glibenclamide | ABCC4 ABCA13 ABCC8 KCNMA1 ABCD1 CACNA1C CACNA1D CALCA PTF1A KCNK13 OPRL1 GUCY1B1 CARD11 LRBA G6PC1 | 9.60e-05 | 382 | 283 | 15 | CID000003488 |
| Drug | 1,5-benzothiazepin-4(5H)-one | 1.02e-04 | 8 | 283 | 3 | CID000358939 | |
| Drug | Nitrendipine | 1.02e-04 | 8 | 283 | 3 | DB01054 | |
| Drug | (1S,2E,3S)-2-[(2E)-2-[(7aR)-7a-methyl-1-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-3-methyl-cyclohexanol | 1.02e-04 | 8 | 283 | 3 | CID011953890 | |
| Drug | isoproterenol | MYO5A PLD3 ITGAM ADRA1D PIK3C2A ABCC8 KCNMA1 MYO18B CACNA1A CACNA1C CACNA1D CACNA1F CALCA LPAR4 TFRC LIPE P2RX7 GUCY1B1 LPAR6 CARD11 LRBA | 1.05e-04 | 669 | 283 | 21 | CID000003779 |
| Drug | DPCPX | 1.09e-04 | 117 | 283 | 8 | CID000001329 | |
| Drug | 2,4,5,2',5'-pentachlorobiphenyl | TNFRSF9 GALR1 PDE7A ABCA13 TOPAZ1 CYP11B1 CYP11B2 ARHGAP11A PTPN1 URB1 NXNL1 SLC8B1 PROKR2 NUP37 KCNMA1 FGD1 SEMA6A CKAP4 DNAH8 CACNA1F POLR1A FAT3 LBR OPRM1 AP4E1 CNNM3 MCTP1 NUP155 PDE4DIP TLR4 LPAR2 GREB1 LRBA ESPL1 XPO7 | 1.17e-04 | 1441 | 283 | 35 | ctd:C009828 |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | LYST ATXN3 CUL4B LZTFL1 FBXO46 CRYL1 IPO9 PDE4DIP GREB1 SLC4A4 | 1.28e-04 | 188 | 283 | 10 | 1667_UP |
| Drug | C768-0445; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 1.28e-04 | 188 | 283 | 10 | 865_UP | |
| Drug | mibefradil | 1.43e-04 | 64 | 283 | 6 | CID000060662 | |
| Drug | NSC759576 | CACNA2D2 IQGAP1 PIK3C2A PKD2 CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F TFRC | 1.46e-04 | 191 | 283 | 10 | CID000003075 |
| Drug | AC1L1I54 | 1.49e-04 | 41 | 283 | 5 | CID000004426 | |
| Drug | Cinnarizine | 1.51e-04 | 9 | 283 | 3 | DB00568 | |
| Drug | gamme | 1.51e-04 | 9 | 283 | 3 | CID000196373 | |
| Drug | Nimodipine | 1.51e-04 | 9 | 283 | 3 | DB00393 | |
| Drug | KN-62 | PLD3 ITGAM CACNA1A CACNA1C CACNA1D CACNA1E GRINA P2RX7 LPAR2 LRBA SLC4A4 | 1.53e-04 | 230 | 283 | 11 | CID000003838 |
| Drug | VRA-GlcNAc | 1.54e-04 | 2 | 283 | 2 | CID006439204 | |
| Drug | cyadox | 1.54e-04 | 2 | 283 | 2 | ctd:C020728 | |
| Drug | 18-hydroxydeoxycorticosterone | 1.54e-04 | 2 | 283 | 2 | ctd:C042509 | |
| Drug | 5-apthp | 1.54e-04 | 2 | 283 | 2 | CID003083389 | |
| Drug | carbachol | GALR1 MYO5A CACNA2D2 PLD3 ADRA1D PIK3C2A PI4KA PKD2 KCNMA1 CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F HTR1A CALCA LBR GUCY1B1 CARD11 LRBA SLC4A4 | 1.54e-04 | 688 | 283 | 21 | CID000002551 |
| Drug | Promethazine hydrochloride [58-33-3]; Down 200; 12.4uM; HL60; HT_HG-U133A | CMTR1 ADRA1D LMF2 PACS2 ATP8B2 AP4E1 CRYL1 LPAR6 TNK2 TMEM19 | 1.59e-04 | 193 | 283 | 10 | 3100_DN |
| Drug | dihydropyridine | CACNA2D2 CYP11B2 PKD2 CACNA1A CPA6 CACNA1C CACNA1D CACNA1E CACNA1F LRBA | 1.59e-04 | 193 | 283 | 10 | CID000104822 |
| Drug | GTP[S] | GALR1 CACNA2D2 PLD3 SSTR4 LYST IQGAP1 PI4KA PKD2 KCNMA1 CACNA1A CACNA1C CACNA1D CACNA1E HTR1A OPRL1 OPRM1 GUCA1B RXFP4 LRBA | 1.65e-04 | 591 | 283 | 19 | CID000001764 |
| Drug | 3-(1H-pyrrole-2-carboxylate | SLC8B1 PKD2 KCNMA1 CACNA1A CACNA1C CACNA1D CACNA1E LIPE GUCY1B1 CARD11 LRBA | 1.71e-04 | 233 | 283 | 11 | CID000005114 |
| Drug | LY320135 | 1.72e-04 | 23 | 283 | 4 | CID005311257 | |
| Drug | Berberine chloride [633-65-8]; Down 200; 10.8uM; PC3; HT_HG-U133A | 1.80e-04 | 196 | 283 | 10 | 7143_DN | |
| Drug | Nitrocaramiphen hydrochloride; Up 200; 10.8uM; MCF7; HT_HG-U133A | 1.80e-04 | 196 | 283 | 10 | 6504_UP | |
| Drug | Betazole hydrochloride; Down 200; 27uM; PC3; HT_HG-U133A | NCKAP1 LMF2 CTC1 ST7 RNF170 RANBP17 METTL25B MCTP1 LPAR6 XPO7 | 1.80e-04 | 196 | 283 | 10 | 6344_DN |
| Drug | Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Down 200; 17.8uM; MCF7; HT_HG-U133A | BBS9 DLC1 FGD1 ANAPC5 CACNA1D PREX2 AP4E1 PDE4DIP MAPKBP1 XPO7 | 1.80e-04 | 196 | 283 | 10 | 5276_DN |
| Drug | manidipine | 1.85e-04 | 95 | 283 | 7 | CID000004008 | |
| Drug | haloperidol; Up 200; 10uM; MCF7; HT_HG-U133A | CACNA2D2 ARHGAP11A MAP3K5 ADRA1D ST7 SLC17A5 VPS13D PLEKHA2 MAPKBP1 TMC5 | 1.88e-04 | 197 | 283 | 10 | 7003_UP |
| Drug | Glipizide [29094-61-9]; Down 200; 9uM; MCF7; HT_HG-U133A | 1.88e-04 | 197 | 283 | 10 | 1508_DN | |
| Drug | Ethionamide [536-33-4]; Up 200; 24uM; MCF7; HT_HG-U133A | CACNA2D2 URB1 SLC8B1 FGD1 SEMA6A ANKFY1 TSPAN1 OPRM1 SERPINE1 TNK2 | 1.88e-04 | 197 | 283 | 10 | 4418_UP |
| Drug | Gliclazide [21187-98-4]; Down 200; 12.4uM; MCF7; HT_HG-U133A | TSPYL2 EDC4 PKD2 FAM118A PREX2 TSPAN1 RNF170 CRYL1 VPS13D SLC4A4 | 1.88e-04 | 197 | 283 | 10 | 5514_DN |
| Drug | Homatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A | NAGLU BBS9 DLC1 ALDOC ARMC7 ATP8B2 SLC17A5 METTL25B IPO9 TNK2 | 1.88e-04 | 197 | 283 | 10 | 5477_DN |
| Drug | Atracurium besylate [64228-81-5]; Down 200; 3.2uM; PC3; HT_HG-U133A | TRADD BBS9 ANAPC5 POLG ATP8B2 VPS13D GTF3C2 ELMO2 LPAR2 XPO7 | 1.96e-04 | 198 | 283 | 10 | 1824_DN |
| Drug | Lidocaone hydrochloride [73-78-9]; Up 200; 14.8uM; MCF7; HT_HG-U133A | CACNA2D2 ADGRB2 DLC1 ENGASE ZBTB33 POLG MCTP1 TLR5 GREB1 SLC4A4 | 1.96e-04 | 198 | 283 | 10 | 1499_UP |
| Drug | Urosiol [128-13-2]; Down 200; 10.2uM; PC3; HT_HG-U133A | TRADD UBE2J1 ANKFY1 POLG FBXO46 DENND3 RANBP17 METTL25B FARP1 PCBP2 | 1.96e-04 | 198 | 283 | 10 | 7243_DN |
| Drug | gadolinium | CACNA2D2 ADGRV1 AGL PKD2 ABCD1 CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F | 2.04e-04 | 199 | 283 | 10 | CID000023982 |
| Drug | Ro 31-8220 | GALR1 PLD3 PIK3C2A KCNMA1 HTR1A LPAR4 OPRL1 P2RX7 LPAR6 SERPINE1 LTC4S LRBA GABRA6 | 2.07e-04 | 321 | 283 | 13 | CID000005083 |
| Disease | Timothy syndrome (implicated_via_orthology) | 3.29e-06 | 4 | 278 | 3 | DOID:0060173 (implicated_via_orthology) | |
| Disease | Ciliopathies | 1.00e-05 | 110 | 278 | 8 | C4277690 | |
| Disease | Conn Syndrome | 1.62e-05 | 6 | 278 | 3 | C1384514 | |
| Disease | Hyperaldosteronism | 1.62e-05 | 6 | 278 | 3 | C0020428 | |
| Disease | hereditary ataxia (implicated_via_orthology) | 2.82e-05 | 7 | 278 | 3 | DOID:0050951 (implicated_via_orthology) | |
| Disease | Glucocorticoid-remediable aldosteronism | 8.84e-05 | 2 | 278 | 2 | C1260386 | |
| Disease | Gastrointestinal defect and immunodeficiency syndrome | 8.84e-05 | 2 | 278 | 2 | cv:C5234880 | |
| Disease | adrenal cortical adenoma (is_marker_for) | 8.84e-05 | 2 | 278 | 2 | DOID:0050891 (is_marker_for) | |
| Disease | androstenedione measurement | 9.45e-05 | 10 | 278 | 3 | EFO_0007972 | |
| Disease | Disorder of eye | 1.96e-04 | 212 | 278 | 9 | C0015397 | |
| Disease | Mood Disorders | 2.04e-04 | 168 | 278 | 8 | C0525045 | |
| Disease | dementia, Parkinson disease, disease progression measurement | 2.64e-04 | 3 | 278 | 2 | EFO_0008336, MONDO_0001627, MONDO_0005180 | |
| Disease | primary immunodeficiency disease (implicated_via_orthology) | 2.64e-04 | 3 | 278 | 2 | DOID:612 (implicated_via_orthology) | |
| Disease | congenital adrenal hyperplasia (implicated_via_orthology) | 2.64e-04 | 3 | 278 | 2 | DOID:0050811 (implicated_via_orthology) | |
| Disease | familial hemiplegic migraine 1 (implicated_via_orthology) | 2.64e-04 | 3 | 278 | 2 | DOID:0111181 (implicated_via_orthology) | |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 2.79e-04 | 14 | 278 | 3 | DOID:898 (implicated_via_orthology) | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 3.58e-04 | 36 | 278 | 4 | DOID:11723 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | ABCC4 TNFRSF9 STARD8 ABCA13 FANCG DLC1 ABCC8 SNX8 DNAH8 RELCH RBP3 PREX2 TFRC P2RX7 TLR4 VRTN GABRA6 | 3.99e-04 | 702 | 278 | 17 | C0009402 |
| Disease | Exudative retinopathy | 5.24e-04 | 4 | 278 | 2 | C0154832 | |
| Disease | gonadal dysgenesis (implicated_via_orthology) | 5.24e-04 | 4 | 278 | 2 | DOID:14447 (implicated_via_orthology) | |
| Disease | semaphorin-6A measurement | 5.24e-04 | 4 | 278 | 2 | EFO_0020721 | |
| Disease | migraine (implicated_via_orthology) | 5.24e-04 | 4 | 278 | 2 | DOID:6364 (implicated_via_orthology) | |
| Disease | thrombosis (is_marker_for) | 5.24e-04 | 4 | 278 | 2 | DOID:0060903 (is_marker_for) | |
| Disease | Bipolar Disorder | ABCA13 ITGAM ITIH4 PROKR2 DNAH8 CACNA1A CACNA1C CACNA1D HTR1A POLG PPP2R2C P2RX7 TLR4 | 6.54e-04 | 477 | 278 | 13 | C0005586 |
| Disease | depressive symptom measurement | CACNA2D2 TOPAZ1 TMPRSS5 TENM2 ITIH4 CACNA1A CACNA1E CARMIL1 CRB1 FARP1 TLR4 LARGE1 | 7.87e-04 | 426 | 278 | 12 | EFO_0007006 |
| Disease | Polydactyly | 8.65e-04 | 117 | 278 | 6 | C0152427 | |
| Disease | primary hyperaldosteronism (is_implicated_in) | 8.68e-04 | 5 | 278 | 2 | DOID:446 (is_implicated_in) | |
| Disease | Leigh Disease | 1.00e-03 | 47 | 278 | 4 | C0023264 | |
| Disease | cerebral infarction (implicated_via_orthology) | 1.29e-03 | 6 | 278 | 2 | DOID:3526 (implicated_via_orthology) | |
| Disease | unipolar depression, bipolar disorder, mental or behavioural disorder | 1.29e-03 | 6 | 278 | 2 | EFO_0000677, EFO_0003761, MONDO_0004985 | |
| Disease | mental development measurement | 1.63e-03 | 25 | 278 | 3 | EFO_0008230 | |
| Disease | apolipoprotein L1 measurement | 1.63e-03 | 25 | 278 | 3 | EFO_0021854 | |
| Disease | grapefruit juice consumption measurement | 1.80e-03 | 7 | 278 | 2 | EFO_0010094 | |
| Disease | Epilepsy, Absence, Atypical | 1.80e-03 | 7 | 278 | 2 | C0751124 | |
| Disease | Juvenile Absence Epilepsy | 1.80e-03 | 7 | 278 | 2 | C4317339 | |
| Disease | Morphine Abuse | 1.80e-03 | 7 | 278 | 2 | C0600272 | |
| Disease | Childhood Absence Epilepsy | 1.80e-03 | 7 | 278 | 2 | C4281785 | |
| Disease | Depression, Postpartum | 1.80e-03 | 7 | 278 | 2 | C0221074 | |
| Disease | protocadherin alpha-7 measurement | 1.80e-03 | 7 | 278 | 2 | EFO_0801973 | |
| Disease | Akinetic Petit Mal | 1.80e-03 | 7 | 278 | 2 | C0001890 | |
| Disease | Constipation | 1.80e-03 | 7 | 278 | 2 | C0009806 | |
| Disease | Absence Seizure Disorder | 1.80e-03 | 7 | 278 | 2 | C4553705 | |
| Disease | Epilepsy, Minor | 1.80e-03 | 7 | 278 | 2 | C4552765 | |
| Disease | Absence Epilepsy | 1.80e-03 | 7 | 278 | 2 | C0014553 | |
| Disease | Morphine Dependence | 1.80e-03 | 7 | 278 | 2 | C0026552 | |
| Disease | Endogenous Hyperinsulinism | 1.83e-03 | 26 | 278 | 3 | C1257963 | |
| Disease | Exogenous Hyperinsulinism | 1.83e-03 | 26 | 278 | 3 | C1257964 | |
| Disease | Compensatory Hyperinsulinemia | 1.83e-03 | 26 | 278 | 3 | C1257965 | |
| Disease | type 2 diabetes mellitus (is_marker_for) | 1.88e-03 | 136 | 278 | 6 | DOID:9352 (is_marker_for) | |
| Disease | visceral adipose tissue measurement | NAGLU ADGRB2 TRIP12 ABCD1 UNC79 CACNA1C HTR1A CARMIL1 TTC7A RANBP17 IPO9 LARGE1 | 2.19e-03 | 481 | 278 | 12 | EFO_0004765 |
| Disease | Hyperinsulinism | 2.28e-03 | 28 | 278 | 3 | C0020459 | |
| Disease | Malignant neoplasm of prostate | SERPINA3 ABCC4 CYP11B2 NAGLU LRP1B POLK REC8 CALCA CRYL1 TLR4 TLR5 SERPINE1 GREB1 TPBG | 2.29e-03 | 616 | 278 | 14 | C0376358 |
| Disease | Prostatic Neoplasms | SERPINA3 ABCC4 CYP11B2 NAGLU LRP1B POLK REC8 CALCA CRYL1 TLR4 TLR5 SERPINE1 GREB1 TPBG | 2.29e-03 | 616 | 278 | 14 | C0033578 |
| Disease | triacylglycerol 58:6 measurement | 2.39e-03 | 8 | 278 | 2 | EFO_0010440 | |
| Disease | primary ovarian insufficiency (is_implicated_in) | 2.39e-03 | 8 | 278 | 2 | DOID:5426 (is_implicated_in) | |
| Disease | response to angiotensin receptor blocker | 2.78e-03 | 30 | 278 | 3 | EFO_0010735 | |
| Disease | migraine (is_implicated_in) | 3.05e-03 | 9 | 278 | 2 | DOID:6364 (is_implicated_in) | |
| Disease | familial Mediterranean fever (is_implicated_in) | 3.05e-03 | 9 | 278 | 2 | DOID:2987 (is_implicated_in) | |
| Disease | Oxidative Phosphorylation Deficiencies | 3.05e-03 | 9 | 278 | 2 | C0949856 | |
| Disease | Mitochondrial Respiratory Chain Deficiencies | 3.05e-03 | 9 | 278 | 2 | C0949857 | |
| Disease | Electron Transport Chain Deficiencies, Mitochondrial | 3.05e-03 | 9 | 278 | 2 | C0949855 | |
| Disease | protein FAM163B measurement | 3.05e-03 | 9 | 278 | 2 | EFO_0802936 | |
| Disease | Retinitis Pigmentosa | 3.08e-03 | 104 | 278 | 5 | C0035334 | |
| Disease | Obesity | 3.43e-03 | 205 | 278 | 7 | C0028754 | |
| Disease | smoking status measurement | GBF1 GALR1 PDE7A ADGRB2 TMPRSS5 TENM2 SH3YL1 DLC1 KIF2B DNAH8 UNC79 CACNA1C CACNA1D POLR1A FAT3 RANBP17 PPP2R2C MCTP1 TLR4 SERPINE1 GABRA6 | 3.45e-03 | 1160 | 278 | 21 | EFO_0006527 |
| Disease | Behcet's disease (is_marker_for) | 3.66e-03 | 33 | 278 | 3 | DOID:13241 (is_marker_for) | |
| Disease | unipolar depression, bipolar disorder | 3.71e-03 | 156 | 278 | 6 | EFO_0003761, MONDO_0004985 | |
| Disease | nephrogenic diabetes insipidus (implicated_via_orthology) | 3.79e-03 | 10 | 278 | 2 | DOID:12387 (implicated_via_orthology) | |
| Disease | ankylosing spondylitis (is_marker_for) | 3.79e-03 | 10 | 278 | 2 | DOID:7147 (is_marker_for) | |
| Disease | cell growth regulator with EF hand domain protein 1 measurement | 4.60e-03 | 11 | 278 | 2 | EFO_0801461 | |
| Disease | 3-hydroxyanthranilate 3,4-dioxygenase measurement | 4.60e-03 | 11 | 278 | 2 | EFO_0021862 | |
| Disease | response to virus | 4.60e-03 | 11 | 278 | 2 | GO_0009615 | |
| Disease | osteosarcoma (is_marker_for) | 4.60e-03 | 11 | 278 | 2 | DOID:3347 (is_marker_for) | |
| Disease | Necrotizing encephalopathy, infantile subacute, of Leigh | 4.69e-03 | 36 | 278 | 3 | C2931891 | |
| Disease | Leigh Syndrome due to Mitochondrial Complex V Deficiency | 4.69e-03 | 36 | 278 | 3 | C1850600 | |
| Disease | interleukin 16 measurement | 4.69e-03 | 36 | 278 | 3 | EFO_0008173 | |
| Disease | Leigh Syndrome due to Mitochondrial Complex III Deficiency | 4.69e-03 | 36 | 278 | 3 | C1850598 | |
| Disease | Leigh Syndrome Due To Mitochondrial Complex II Deficiency | 4.69e-03 | 36 | 278 | 3 | C1850597 | |
| Disease | Leigh Syndrome due to Mitochondrial Complex IV Deficiency | 4.69e-03 | 36 | 278 | 3 | C1850599 | |
| Disease | Prescription Drug Abuse | 4.74e-03 | 115 | 278 | 5 | C4316881 | |
| Disease | Substance-Related Disorders | 4.74e-03 | 115 | 278 | 5 | C0236969 | |
| Disease | Organic Mental Disorders, Substance-Induced | 4.74e-03 | 115 | 278 | 5 | C0029231 | |
| Disease | Drug habituation | 4.74e-03 | 115 | 278 | 5 | C0013170 | |
| Disease | Drug abuse | 4.74e-03 | 115 | 278 | 5 | C0013146 | |
| Disease | Drug Use Disorders | 4.74e-03 | 115 | 278 | 5 | C0013222 | |
| Disease | Drug Dependence | 4.74e-03 | 115 | 278 | 5 | C1510472 | |
| Disease | Substance Dependence | 4.74e-03 | 115 | 278 | 5 | C0038580 | |
| Disease | Substance Use Disorders | 4.74e-03 | 115 | 278 | 5 | C0038586 | |
| Disease | Seizures | 4.78e-03 | 218 | 278 | 7 | C0036572 | |
| Disease | Substance abuse problem | 4.91e-03 | 116 | 278 | 5 | C0740858 | |
| Disease | response to radiation, prostate carcinoma, erectile dysfunction | 5.07e-03 | 37 | 278 | 3 | EFO_0001663, EFO_0004234, GO_0009314 | |
| Disease | LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY | 5.07e-03 | 37 | 278 | 3 | C1838951 | |
| Disease | juvenile idiopathic arthritis | 5.29e-03 | 74 | 278 | 4 | EFO_0002609 | |
| Disease | nitric oxide exhalation measurement | 5.47e-03 | 38 | 278 | 3 | EFO_0005536 | |
| Disease | collagen disease (implicated_via_orthology) | 5.48e-03 | 12 | 278 | 2 | DOID:854 (implicated_via_orthology) | |
| Disease | Bardet-Biedl Syndrome | 6.44e-03 | 13 | 278 | 2 | C0752166 | |
| Disease | Combined immunodeficiency | 6.77e-03 | 41 | 278 | 3 | C0494261 | |
| Disease | complement factor H measurement | 6.77e-03 | 41 | 278 | 3 | EFO_0008097 | |
| Disease | Inflammation | 7.17e-03 | 127 | 278 | 5 | C0021368 | |
| Disease | volumetric bone mineral density | 7.24e-03 | 42 | 278 | 3 | EFO_0007620 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AALAFRFVEVLLINN | 176 | O60241 | |
| EARLLLAALVQDYVQ | 46 | P06881 | |
| NYTLLNVFLAIAVDN | 701 | O00555 | |
| VIYQNRLALDYLLAQ | 546 | Q14264 | |
| IIAIAATNNLYIFQD | 426 | Q9Y2T4 | |
| VSVLRAAFYVAAQLL | 81 | P41181 | |
| NFQLVLEYSDAILIN | 1451 | Q8NDM7 | |
| RVENIYLLNLAVSNL | 71 | O00421 | |
| QAVRLAQNILSYLDL | 426 | Q9UL15 | |
| LRDFYQEELQLLILS | 101 | A6NC98 | |
| ARVYVQFFLADALIL | 686 | Q2NKJ3 | |
| NYTLLNVFLAIAVDN | 691 | Q15878 | |
| RDQDLNTYSLLAVFA | 746 | Q9NY47 | |
| RALNFLFYLALVAAA | 106 | Q07065 | |
| FSISRDYNLNDILLQ | 316 | P01011 | |
| DLSFYVNRLSSLVIQ | 216 | Q5JQC9 | |
| ALYLFLTARNLTVVN | 621 | Q9UHX3 | |
| LVVVVDNIRYLFSQS | 211 | O43506 | |
| ALAILENANVLARYA | 161 | P09972 | |
| RNSIQIYLLNVAIAD | 86 | Q9UPC5 | |
| LLTNDNEVLYRIYAA | 5831 | Q8WXG9 | |
| QLSLRRYFADLIAIV | 36 | Q5T5M9 | |
| ALNTVYAIRNASDLF | 916 | Q86UQ4 | |
| AVVQDLSLTFYRDQI | 3856 | Q86UQ4 | |
| LLVQEDLTRYQFQSL | 326 | Q6NUN0 | |
| LIQVASREQLLYLYA | 56 | Q9BR61 | |
| LEAYVLLSSEQLFLR | 116 | Q9NVE4 | |
| ALLDFQNLYKTDIRI | 576 | A2RUS2 | |
| SRALLAFLQEANIQY | 91 | Q8N4T0 | |
| IQLALVIARLYESEF | 1721 | Q9Y485 | |
| RANLQLLDDSIAIYI | 146 | Q96MT7 | |
| LELLSEVQLQQYFLR | 11 | Q07912 | |
| LLVGNQISLLRAFFY | 76 | P55064 | |
| QISLLRAFFYVAAQL | 81 | P55064 | |
| LDLTRQAVQELVSLY | 561 | P54802 | |
| QLRLYAVQSYLTLLD | 486 | Q9UPM8 | |
| ALAVFSEVEYLNVRL | 81 | Q8NCT1 | |
| ITYQLLAILDFNNIR | 546 | P98198 | |
| LRNQALNLSLAYSFV | 571 | Q14624 | |
| AAQQYQRRLAAVALI | 381 | P46940 | |
| LSRLTILYLFNNSLA | 226 | Q86UN3 | |
| RTLQFLNDLSVGYIL | 611 | Q9H2T7 | |
| AARVFYLLLVLSAQQ | 511 | O95072 | |
| LYTRNNAREQLEVLF | 801 | Q4ADV7 | |
| NLIAVSNSFLAYAIR | 136 | Q6P2E9 | |
| FQQALTAADLNLVLY | 1281 | Q6P2E9 | |
| VVLQALFYLLDRAVD | 126 | P43378 | |
| ILVNSFQLLYVVDAL | 421 | Q14739 | |
| AYNLLKRNLFAEIIE | 316 | Q9NWY4 | |
| AELQFYLVVALALIS | 686 | Q9Y5F9 | |
| DLQAELQFYLVVALA | 681 | Q9UN71 | |
| LAQYLINQTLLLARD | 1211 | Q9UPP5 | |
| FVNSAIRYLEGQLAL | 146 | P33897 | |
| LQYLASETVLNLAFA | 616 | Q9UJX4 | |
| FNYQVATKQLLFRLL | 1081 | Q9P2R3 | |
| AIAAQLLRDQYLLTA | 96 | Q9P260 | |
| NYILLNVFLAIAVDN | 746 | O60840 | |
| LLNVVDNARSFIYVA | 311 | Q8IV08 | |
| TLRYANQARLIVNIA | 691 | Q15058 | |
| EQYRILLFNDSVVLL | 406 | P23467 | |
| NIYIFNLALADALAT | 106 | P35372 | |
| IQTADQLRFSYLAVI | 261 | P18031 | |
| LALYLSDAEAQQFLR | 501 | O95461 | |
| TLRVLNLEYNQLTTF | 281 | A4D1F6 | |
| FLRELNVLDYSLLIA | 271 | Q5T9C9 | |
| NRYTSLFLIVNSVIL | 231 | P48060 | |
| LLIANFETIEVFYLN | 206 | Q9NZR2 | |
| FIYLQEALQDSRALT | 311 | Q2Q1W2 | |
| FAALNLYTDIINIFL | 346 | Q7Z429 | |
| YAIDNNELLDFLSRV | 956 | Q6DN14 | |
| TAYTNVLLLRQLFAQ | 76 | Q9NQ48 | |
| YFNDNILTLIRTLVT | 1051 | Q12791 | |
| IFLVLVQRYQEFINT | 576 | Q8IV33 | |
| YFLLLAEANSLVNAA | 276 | Q9HBW0 | |
| IFSQLYLEAEQQLAA | 36 | Q4ZG55 | |
| SFIRAEIFAEILNYI | 71 | Q86T24 | |
| DAIRVFANILLYIQR | 331 | Q9Y262 | |
| LEYRALEQQFTQLLV | 596 | Q17R60 | |
| NSVLFLYALVRSQAI | 266 | Q99677 | |
| YIQLFRNLAKAIATD | 606 | Q9NR71 | |
| YSVNNLESFQRVELL | 86 | Q9NYS0 | |
| ELISDTYLALFLAQL | 141 | P54252 | |
| IYAARDAQISVALFL | 241 | Q9NVH0 | |
| VALVEQRAALALQSY | 176 | Q6PJ61 | |
| VLLQAYFSLQVISAR | 16 | Q16873 | |
| SYIHILQAVFRLLSQ | 236 | Q8NGF0 | |
| IYLNSSLVQFLLSRA | 986 | O00443 | |
| ALILATDISRQNEYL | 316 | Q13946 | |
| AIQSLINLLADNRYL | 341 | Q9HCD5 | |
| FNTLLRQLRLSIDYA | 336 | Q9Y2G0 | |
| ISQLHYALQATLFVR | 576 | Q96JB1 | |
| NLAVYDLSRDILNNF | 56 | Q5H943 | |
| SIRQLQLFINEYDTI | 2681 | Q6ZR08 | |
| RYRAALALQITNLLT | 1146 | P54098 | |
| VIVEAFLASLSNRLY | 586 | P42356 | |
| INLNFDFTRSYLDLI | 121 | P55160 | |
| QYLARFDALVLSDII | 431 | P55160 | |
| IFSRRYLLQNTALEI | 2141 | P50851 | |
| VLYLAGNQLARLLDF | 126 | Q50LG9 | |
| LSASYTRLFLILNIA | 896 | Q9UL01 | |
| RASFLQNAVLAYVQA | 646 | Q96CN5 | |
| TAFYLQLFLLDIAQI | 61 | A6NFX1 | |
| NFYSENVSRILDNLL | 26 | Q16445 | |
| NDVYRAANSLLRLAV | 496 | P36915 | |
| IVNLLNDLYTRFDTL | 446 | Q02153 | |
| DNARFLLLAALIVLY | 16 | Q9HB14 | |
| DLVYLDFRNNSLRSL | 81 | Q5VT99 | |
| NINLILYSLVRTQTF | 246 | P43657 | |
| QLAVNLTRVLALYRS | 16 | Q96FB5 | |
| NLLLFYNLSQVREAD | 116 | Q96KJ4 | |
| EYLRQLQVLDLFLDS | 51 | Q9H6L4 | |
| VLLTAFAYRQGLQEL | 206 | O15287 | |
| RFYDLLAQQAILSLE | 191 | Q8NFH4 | |
| QAELQFYLVVALALI | 681 | Q9Y5G0 | |
| AQHYLSAILRLFVEQ | 556 | Q86VP3 | |
| SRIYFLNQLGDLALS | 846 | Q9H0A0 | |
| LITNELILRLQEYFE | 611 | Q3SYG4 | |
| YVQIDITRVFNNVLL | 756 | Q9Y2A7 | |
| LQQRLEYIARAILSA | 1111 | O75694 | |
| ALEYLRQIFRLSEAQ | 661 | Q9NXE4 | |
| RLAIGYINFLSELVQ | 206 | Q7RTS3 | |
| AASISLAQYLINVRL | 341 | Q15366 | |
| FQSQFERLVILDYII | 286 | Q8TCG2 | |
| QAAEYNRVVSLLVLV | 266 | Q8NGU1 | |
| FLILLNTAAQVAYVL | 716 | O15439 | |
| SLVFTAVERYQLIVN | 126 | Q99463 | |
| LVLSRHVLQFLLLYQ | 516 | Q99572 | |
| AEYSNQARLVEFLIT | 866 | Q52LW3 | |
| LLTLANTIGLQFQRY | 296 | A8MW95 | |
| LLYLIQNDDNFLNII | 586 | Q8IZD4 | |
| NLFILNLSIADLAYL | 71 | P47211 | |
| TLDDAQFVLNRVLYR | 1046 | A4FU69 | |
| ETLRDQIFQALFLYS | 236 | Q9NWS6 | |
| RLTCFIRLNDYLIEN | 436 | Q9C0G6 | |
| YLERILFVLLRNAAA | 96 | Q14674 | |
| NRFEVLTFLLLCYNA | 176 | Q9BYI3 | |
| AILRNSAEVLYQIAN | 546 | Q13099 | |
| NSNLERVEYLFLIIF | 156 | Q13936 | |
| NYILLNVFLAIAVDN | 741 | Q13936 | |
| RNYFNILDLLVVSVS | 986 | Q13936 | |
| SNLKEYSRLLNAFIV | 86 | Q8N0S6 | |
| LYVLQVLTFNLLEER | 286 | Q96JJ3 | |
| LLTRTNVNFQYISLR | 126 | Q53EU6 | |
| QLQEELTRYLFALQV | 126 | Q9Y4F1 | |
| LTRYLFALQVKQDLA | 131 | Q9Y4F1 | |
| ILVSVIADLRNAFYV | 31 | P35575 | |
| RSLAYNRIVDALNEF | 386 | Q8TF40 | |
| NLAVIFDLLLDSYRT | 1766 | Q5TH69 | |
| LVELSSLLVRNVNYE | 111 | Q96JB5 | |
| TLLLQVAAFAYQIEE | 111 | P26441 | |
| ILLDYNNQRLIFINA | 4011 | Q8N3K9 | |
| IYFGALVQADNIRSL | 3956 | Q8TDW7 | |
| SASFLRNINEYLAVV | 131 | Q96CU9 | |
| LSRAALYSRLQEFLL | 361 | Q8IX06 | |
| LYSRLQEFLLTQDQL | 366 | Q8IX06 | |
| RSLRNLAADYLAQII | 616 | Q8IX06 | |
| FLERVASSDLVLQNY | 381 | P15538 | |
| QIRLLSQIYAAVIEA | 366 | Q5TEA3 | |
| AQSVILRRYFLELTQ | 431 | Q8IWF6 | |
| IALERSLQNVANYLI | 61 | P08908 | |
| LTVLAVNRIIYQEFN | 2646 | Q99698 | |
| DVNSIELRFQSAVLY | 136 | O00462 | |
| TQALLEQYSELLLRA | 1491 | O60336 | |
| YTVRIAAQDLLLAVA | 396 | Q96P70 | |
| LFQLLSIERLNLYAA | 461 | Q92538 | |
| YIQDLVTLTNLRINF | 216 | A4D0S4 | |
| LQYLAVLNLSRTVFS | 391 | Q5VZK9 | |
| AGFVLNRLQYAIISE | 191 | Q9Y2S2 | |
| FLERVVSSDLVLQNY | 381 | P19099 | |
| FATQYRIVDLLVEAA | 691 | Q8NFI3 | |
| LTLQILARYSVFVNE | 446 | Q14746 | |
| LLLALENSTYQYIRV | 751 | P82279 | |
| VAFLSSYQILTRQLQ | 281 | Q9BRL7 | |
| FIVYALRVNLSVALV | 51 | Q9NRA2 | |
| VFQIAVNLNVERYAL | 391 | Q9BZV2 | |
| FYIRLNLNISSQLDA | 776 | Q9BXL7 | |
| YILLNVFLAIAVDNL | 741 | Q01668 | |
| DENRIQDLSLLYQLF | 466 | Q13620 | |
| ASQEFLNYLRTNALI | 761 | B7ZC32 | |
| VRDYLFAVNIKLNQL | 456 | Q8N1G2 | |
| VFGAYFNVLINLRDI | 491 | O95954 | |
| LVAQDVFLLLRNSTY | 331 | Q8N4N8 | |
| LAALTQLRALVYYAQ | 416 | Q05469 | |
| FYQETTAQILVRALN | 296 | Q6J4K2 | |
| DQLTRLVLVNALYFN | 181 | P05121 | |
| NFILASFLTYLQQEI | 956 | Q5HYA8 | |
| TNIYIFNLALADTLV | 86 | P41146 | |
| AVLLLDTRQFLIYNE | 16 | P22897 | |
| ADIVINLLLSYRDIQ | 311 | Q99683 | |
| QKSVRQYATDFLLLA | 1246 | Q8NET4 | |
| TTSYLLLLAFLQRRQ | 221 | Q8TDU9 | |
| LRRYFILDTQANCLL | 26 | Q9HB19 | |
| YLLRIANFSNLIFLR | 106 | P59541 | |
| VFLEQALIQYALRTL | 201 | P49591 | |
| LENIFSLLFRIVYNQ | 76 | P59535 | |
| LRLQAAVVQTLIDYA | 221 | Q6P4F7 | |
| ALQAVYELERILNRF | 131 | O95602 | |
| RSQFYIALKLVAVAQ | 66 | Q96D71 | |
| AQFAISRELIRNIYN | 216 | Q9Y5X2 | |
| QCLQALYVDSLFFLR | 296 | P78395 | |
| LYEQAFQLLRRFVQA | 261 | Q15628 | |
| RLAAFYSQVLLQVLI | 251 | Q9BU23 | |
| TRQNRFEIVYNLLSL | 121 | O75489 | |
| FEIVYNLLSLRFNSR | 126 | O75489 | |
| LYFINLAVADLILVA | 96 | Q99527 | |
| NTIDFLEYVAALNLV | 71 | Q9UMX6 | |
| QLVAEFSSVLLRLEY | 256 | A3QJZ6 | |
| TTQDRYLILFNDRLL | 606 | P98174 | |
| ILNYSIFNRENDLLA | 191 | Q8TE76 | |
| LVIILNYDRAVEAFA | 101 | Q96HL8 | |
| ATNIYLLNLAVADEL | 81 | P31391 | |
| YVVQLLNLFVTSLDA | 276 | P31391 | |
| LIATLVYALFRNVHQ | 36 | Q96K19 | |
| RLQADDFLQDYTLLI | 516 | Q9UBT2 | |
| TLLLQELVSFQERIY | 691 | Q93073 | |
| DNSLYVLENNVILRI | 1426 | Q9NT68 | |
| TSDVLRFVLEQYNAL | 2126 | Q9UHV7 | |
| EFYTFVNLLDVARAL | 426 | Q6IE81 | |
| YAAAIILRNRVQSLV | 406 | P11215 | |
| ELNLVRIAIQNLLYY | 216 | Q8WTW4 | |
| ALLELQAYADVQAVL | 341 | Q9NRC1 | |
| VSIYILNLAAADFLF | 61 | Q96LA9 | |
| IILFISRNRQFSYLI | 141 | Q9Y399 | |
| ENREVLQTLLYFLSD | 1196 | Q96QB1 | |
| SQLLSFVRDLNQYRA | 616 | P02786 | |
| RFQEQSQLLYLLDVV | 1701 | O60287 | |
| SLALRILFYRSNVIN | 161 | Q8NGL0 | |
| NREVLQTLLYFLSDI | 691 | Q92502 | |
| AYLLAACILNFQRAL | 91 | O43868 | |
| VTLYFLSLLVFRLQN | 761 | Q9NRP7 | |
| LQTALLVLQYFADAA | 741 | Q9NRC6 | |
| NYLFRLQLEDLSLIQ | 76 | Q13591 | |
| FLANAYVLAVLLFLA | 351 | Q09428 | |
| EARLLLAALVQDYVQ | 46 | P01258 | |
| TNYFIVNLAVADLLL | 131 | P25100 | |
| NTEYLFELANSIRNL | 141 | Q8WUX2 | |
| QTRFARLLAEYNATQ | 641 | Q16281 | |
| LASLAQAALAVLLYR | 201 | Q8NE01 | |
| VTRLQYLNALLATRA | 641 | Q8NE01 | |
| STNALLAIAIDRYLA | 151 | Q8TCW9 | |
| LINSLFLTNLYEDRQ | 46 | Q8WYJ6 | |
| TIVRLAYAENIALLA | 476 | Q99570 | |
| AVTIALLVYFLAFDQ | 31 | O60235 | |
| LSLQFLLLSYDLFVN | 11 | Q9NPI0 | |
| QQSAYFLLTLFREVA | 4366 | Q63HN8 | |
| NFSNLEIIYLSENRI | 416 | Q9NR97 | |
| ENYRNLVFLAGIALT | 66 | Q8IYN0 | |
| QRLQLYLTLGAAAFQ | 266 | O95070 | |
| SVFQRYLALANQVLS | 221 | Q9C0E2 | |
| LYRVAAVLLQFNLID | 266 | Q8NI27 | |
| QYLFRNALEIASEIL | 221 | Q9HAW8 | |
| DIFRYLTNLQVQDLR | 286 | Q9H2G4 | |
| QLVDTAALVIDLRYN | 771 | P10745 | |
| LTDEFYVLRAAQLAL | 61 | Q96CM4 | |
| NAFIEESRQLLSYAL | 116 | Q5PRF9 | |
| RTQYQLSRADLVLLA | 201 | Q8WZ04 | |
| FYFNILQAVTDVIRI | 291 | Q9H2E6 | |
| VLASLRDNLYLLQAF | 81 | O95858 | |
| LYQQRALLSLLFSET | 376 | Q9UBT6 | |
| YNIVATLLLVLNFER | 6 | Q07011 | |
| SLFNLLEFRRLVLNY | 186 | Q9UHP3 | |
| DYDVALLRLQTALNF | 306 | Q9H3S3 | |
| LALAALIFRRIYLAN | 296 | Q9Y385 | |
| VSTNALLAIAIDRYL | 141 | Q8NFJ6 | |
| LNALDELYRLVASFI | 1476 | Q70Z35 | |
| IYRTSNVEVLLQFLE | 526 | Q13563 | |
| VNLFARLATDNIGYI | 256 | Q14997 | |
| FIVAASNLRAENYDI | 861 | P22314 | |
| YQELFAAVVSLINRS | 916 | Q8IUG5 | |
| YFDLQVLNDLLNSLL | 1161 | Q8N9V7 | |
| NYRNLVFLGIAVSNL | 36 | P17019 | |
| ENYRNLVFLAGIAVS | 66 | Q9H8G1 | |
| AYFLTQLIFVNDLDI | 236 | Q96HH6 | |
| LQLAIQFLFQTYLRT | 2166 | Q9UPU5 | |
| QAAFYLALQLAISRQ | 516 | Q86TV6 | |
| ATFVTQALIQLYARI | 101 | Q9UIA9 | |
| LQNAAAIYDLLSITL | 376 | Q9ULT0 | |
| NIQALSAILFIYLAT | 466 | Q9Y6R1 | |
| RAAQVALLYLQELAE | 186 | Q8WUA4 | |
| AYVRNLFLTGNQLAV | 91 | Q13641 | |
| FDIARNVLELIYAQT | 771 | Q6UXY8 | |
| NQLSVDTLQFLLFLY | 111 | Q9NVR7 | |
| VFLLQNNLVELYSLN | 381 | Q9UNX4 | |
| LLAILSQTEFYEALR | 256 | Q8IWY8 | |
| ILAINQVFDILSTYL | 276 | Q6PF06 | |
| SENRLENLDILYFLL | 431 | O60602 | |
| LYALASVLQRNIYSI | 176 | Q9H8Y1 | |
| FYQVAALQGDLASLR | 66 | Q9Y275 | |
| FYALEFNLADLVISI | 561 | Q5VYS8 | |
| DAFQGLRSLNSLVLY | 351 | O75093 | |
| TLEFYALVSQELQRA | 1631 | Q14669 | |
| SVFLSLRNLIYLDIS | 441 | O00206 | |
| ILQVELVRSLNYLLY | 471 | Q04912 | |
| LDVLSFVLLINRQFY | 466 | P49815 | |
| FNQLLYDIRTNAVTV | 201 | O60635 | |
| SAIQREYLDISFNIL | 1846 | Q9P2D8 | |
| FYLSRSVVLELLQAL | 2256 | Q9P2D8 | |
| LQALDIRLSYNDVQL | 2571 | Q5THJ4 | |
| IRLSYNDVQLFLAIA | 2576 | Q5THJ4 | |
| ASRLTLAELNQILYR | 896 | P35573 | |
| YINVDISVFANATLR | 441 | Q9UQQ1 | |
| LRYQNLLNEFSRLEE | 1076 | Q9Y4I1 | |
| ALQAERQLYSSLVKF | 876 | Q5VU43 |